Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a1 is in GeDiPNet but isn't part of any cluster ‐ it doesn't share enough genes with a group of 5+ diseases to form one. Its strongest one-to-one links are on Shared-Gene Disease Pairs. View disease details →
6,217 of 9,368 diseases (66%) fall into one of 656 clusters. The remaining 3,151 don't share enough genes with a group of 5+ diseases to form one ‐ see Shared-Gene Disease Pairs for their pairwise links.
Cluster ⇵ # Diseases ⇵ Sample members Top biological theme ⇵
Cluster 1 201 Acinic cell breast carcinoma, Adnexal spiradenoma/cylindroma of a sweat gland, Adrenal cortex carcinoma, Adrenal gland neuroblastoma, Adrenal gland pheochromocytoma and 196 more
positive regulation of transcription by RNA polymerase II
GO · q=7.23e-76
Cluster 2 153 Abdominal obesity-metabolic syndrome 3, Acantholytic blistering of oral and laryngeal mucosa, Acinar lung adenocarcinoma, Acral lentiginous melanoma, Acute myeloid leukemia and 148 more
positive regulation of transcription by RNA polymerase II
GO · q=7.39e-57
Cluster 3 65 1q44 microdeletion syndrome, Aspartylglucosaminuria, Cardiofacio-neurodevelopmental syndrome, Complex neurodevelopmental disorder, Congenital neurologic anomalies and 60 more
nervous system development
GO · q=1.36e-44
Cluster 4 58 3-methylcrotonyl-coa carboxylase deficiency, Alopecia-neurological defects-endocrinopathy syndrome, Alzheimer disease, Anxiety disorder, Attention deficit hyperactivity disorder and 53 more
nervous system development
GO · q=2.23e-22
Cluster 5 58 Anti-neutrophil antibody associated vasculitis, Antiphospholipid syndrome, Autoimmune musculoskeletal system disorder, Autoimmune polyendocrine syndrome, Benign hereditary chorea and 53 more
Allograft rejection
Pathway · q=2.06e-17
Cluster 6 56 Al-raqad syndrome, Auditory neuropathy, Auditory neuropathy, autosomal dominant, 1, Autosomal dominant nonsyndromic hearing loss, Congenital ear anomaly and 51 more
sensory perception of sound
GO · q=1.81e-91
Cluster 7 40 Abdominal obesity-metabolic syndrome 4, Acetyl-coa carboxylase deficiency, Arteriosclerosis, Atherosclerosis, Atrial fibrillation and 35 more
positive regulation of transcription by RNA polymerase II
GO · q=5.44e-25
Cluster 8 36 Anaplastic ependymoma, Atypical teratoid rhabdoid tumor, Benign monoclonal gammopathy, Bladder cancer, Bladder urachal adenocarcinoma and 31 more
Pathways in cancer
Pathway · q=4.35e-42
Cluster 9 35 5-oxoprolinase deficiency, Arrhythmogenic right ventricular cardiomyopathy, Atrial flutter, Atrioventricular block, Barth syndrome and 30 more
regulation of heart rate by cardiac conduction
GO · q=2.77e-45
Cluster 10 34 Aminoaciduria, Aneurysm, Aortic aneurysm, Bone marrow failure and diabetes mellitus syndrome, Cardiomyopathy, dilated, 2j and 29 more
skeletal system development
GO · q=1.19e-22
Cluster 11 33 Achromatopsia, Bainbridge-ropers syndrome, Cone dystrophy, Cone rod dystrophy and hearing loss, Cone-rod dystrophy and 28 more
visual perception
GO · q=2.39e-111
Cluster 12 29 Acute leukemia of ambiguous lineage, Acute myeloid leukemia, t(3;5)(q25;q34), B-lymphoblastic leukemia/lymphoma, Blast phase chronic myelogenous leukemia, bcr-abl1 positive, Cd4+/cd56+ hematodermic neoplasm and 24 more
Pathways in cancer
Pathway · q=8.16e-44
Cluster 13 29 Atypical multiple mole melanoma syndrome, Brain stem neoplasms, Bryant-li-bhoj neurodevelopmental syndrome, Childhood cancer retinoblastoma, Clear cell chondrosarcoma and 24 more
Melanoma
Pathway · q=4.29e-16
Cluster 14 27 ALG6-congenital disorder of glycosylation 1C, Alsahan-harris syndrome, Aplasia of the vermis, Bardet-biedl syndrome, Bardet-biedl syndrome 16 and 22 more
cilium assembly
GO · q=4.89e-87
Cluster 15 27 Ciliary dyskinesia, Ciliary dyskinesia, primary, 36, x-linked, Ciliary dyskinesia, primary, 45, Ciliary dyskinesia, primary, 46, Ciliary dyskinesia, primary, 47, and lissencephaly and 22 more
cilium movement
GO · q=3.75e-40
Cluster 16 27 Anisometropia, Atypical ductal hyperplasia, Bannayan-riley-ruvalcaba syndrome, Breast and ovarian cancer, Calcifying epithelial odontogenic tumor and 22 more
Central carbon metabolism in cancer
Pathway · q=3.11e-16
Cluster 17 26 Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency, Combined oxidative phosphorylation deficiency, Cytochrome c oxidase deficiency, Early onset isolated mitochondrial complex i deficiency, Ethylmalonic encephalopathy and 21 more
Respiratory electron transport
Pathway · q=2.38e-72
Cluster 18 26 Amyotrophic lateral sclerosis type 15, Brody myopathy, Cohen syndrome, Congenital hypogonadotrophic hypogonadism, Growth hormone deficiency and 21 more
pituitary gland development
GO · q=5.60e-8
Cluster 19 26 Alpha/beta t-cell lymphopenia, with gamma/delta t-cell expansion, severe cytomegalovirus infection and autoimmunity, Autosomal dominant combined immunodeficiency, Combined cellular and humoral immune defects with granulomas, Combined immunodeficiency, Combined immunodeficiency with granulomatosis and 21 more
immune system process
GO · q=1.85e-24
Cluster 20 24 Acromicric dysplasia, Arachnodactyly, Arc syndrome, Arthrogryposis-renal dysfunction-cholestasis syndrome, Autosomal recessive craniosynostosis and 19 more
Defective B3GALTL causes Peters-plus syndrome (PpS)
Pathway · q=9.01e-7
Cluster 21 23 Achondrogenesis, type ii or hypochondrogenesis, Avascular necrosis of femoral head, Collagenopathy, Congenital hip dysplasia, Coxa plana and 18 more
cartilage development involved in endochondral bone morphogenesis
GO · q=2.11e-3
Cluster 22 23 Allergic contact dermatitis, Arthritis, Atopic dermatitis, Autoimmune hepatitis, Autoinflammation with episodic fever and immune dysregulation and 18 more
immune response
GO · q=2.44e-51
Cluster 23 22 Ankylosing spondylitis, Autoinflammatory-pancytopenia syndrome, Cherubism, Crohn disease, Dental caries and 17 more
inflammatory response
GO · q=2.24e-35
Cluster 24 22 Benign neoplasm of brain, Congenital kidney anomaly, Cortical dysplasia, Epithelioid type angiomyolipoma, Fibroma and 17 more
TORC1 signaling
GO · q=2.68e-6
Cluster 25 22 Adenoma of small intestine, Adenomatous polyposis coli (thyroid papillary carcinoma in patients with apc), Appendix villous adenoma, Bone dysplasia with increased bone density, Brain tumor-polyposis syndrome and 17 more
regulation of cell population proliferation
GO · q=1.46e-8
Cluster 26 20 Biliary tract cancer, Cancer, Cervical cancer, Chromosome 20q11-q12 deletion syndrome, Cutaneous squamous cell carcinoma and 15 more
positive regulation of transcription by RNA polymerase II
GO · q=4.46e-16
Cluster 27 20 Aarskog-scott syndrome, x-linked, Acro-dermo-ungual-lacrimal-tooth syndrome, Ankyloblepharon-ectodermal defects-cleft lip/palate, Bladder exstrophy, Bladder exstrophy and epispadias complex and 15 more
canonical Wnt signaling pathway
GO · q=1.31e-5
Cluster 28 20 Cataract, Cataract 15, multiple types, Cataract 17, multiple types, Cataract 19, multiple types, Cataract 20, multiple types and 15 more
lens development in camera-type eye
GO · q=4.67e-26
Cluster 29 19 Angle closure glaucoma, Avascular necrosis of bone, Chromosome 5q deletion syndrome, Hereditary fructose intolerance, Hypermetabolism due to uncoupled mitochondrial oxidative phosphorylation 2 and 14 more
response to hypoxia
GO · q=1.15e-8
Cluster 30 19 Absence epilepsy, Childhood absence epilepsy, Cranio-cervical dystonia, Dravet syndrome, Early-onset generalized dystonia and 14 more
monoatomic ion transmembrane transport
GO · q=5.31e-25
Cluster 31 19 Ataxia with intention tremor and hypotonia, Cervical dysplasia, Congenital plasminogen activator inhibitor deficiency type 1, Hematologic disease, Hepatic vein thrombosis and 14 more
cellular response to lipopolysaccharide
GO · q=6.77e-9
Cluster 32 19 Bowen's disease, Calcifying nested epithelial stromal tumor of the liver, Cecal neoplasms, Colorectal hamartoma, Ependymoblastoma and 14 more
Thyroid cancer
Pathway · q=2.25e-6
Cluster 33 19 C1 esterase inhibitor deficiency, C1q deficiency, C1s deficiency, C4a deficiency, C4b deficiency and 14 more
complement activation
GO · q=5.46e-73
Cluster 34 18 Adenomyoma of uterine corpus, Cholestasis-pigmentary retinopathy-cleft palate syndrome, Disseminated peritoneal leiomyomatosis, Endometrial polyp, Fg syndrome and 13 more
Cellular senescence
Pathway · q=3.80e-5
Cluster 35 18 Adrenal gland neoplasms, Congenital hereditary endothelial dystrophy, Congenital stromal corneal dystrophy, Corneal disease, Corneal dystrophy and 13 more
visual perception
GO · q=1.74e-7
Cluster 36 17 Abetalipoproteinemia, Carotid artery disease, Congenital hyperinsulinism, Diabetic ketoacidosis, Glycogen storage disease I and 12 more
Maturity onset diabetes of the young
Pathway · q=1.23e-17
Cluster 37 17 Acute disseminated encephalomyelitis, Aortic arch syndrome, Apolipoprotein b hypobetalipoproteinemia, Autoimmune gastritis, Autoimmune pulmonary alveolar proteinosis and 12 more
Type I diabetes mellitus
Pathway · q=5.16e-9
Cluster 38 17 Beta-thalassemia HBB/LCRB, Cooleys anemia, Dominant beta-thalassemia, Erythrocytosis, familial, 6, Hemoglobin c beta thalassemia and 12 more
carbon dioxide transport
GO · q=3.88e-4
Cluster 39 17 Atrial standstill, Cardiac rhythm disease, Dilated cardiomyopathy 1E, Ectopic rhythm, Heart block, nonprogressive and 12 more
regulation of heart rate by cardiac conduction
GO · q=3.60e-7
Cluster 40 16 17q11 microdeletion syndrome, Cervical lymphadenopathy, Collecting duct carcinoma, Embryonal nuclear cataract, Familial spinal neurofibromatosis and 11 more
RAS signaling downstream of NF1 loss-of-function variants
Pathway · q=1.43e-5
Cluster 41 16 17q23.1q23.2 microdeletion syndrome, Amelia, Amelia, posterior, with pelvic and pulmonary hypoplasia syndrome, Arthropathy, Chromosome 17q23.1-q23.2 duplication syndrome and 11 more
embryonic hindlimb morphogenesis
GO · q=5.88e-6
Cluster 42 16 Charcot-marie-tooth disease, Charcot-Marie-Tooth disease axonal type 2P, Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4B3 and 11 more
Cytosolic tRNA aminoacylation
Pathway · q=7.32e-7
Cluster 43 16 Alpha thalassemia x-linked intellectual disability, Alpha-thalassemia intellectual developmental disorder syndrome non-deletion type, Asphyxiating thoracic dystrophy 2, Astroblastoma, Atr-x syndrome and 11 more
chromatin remodeling
GO · q=4.47e-5
Cluster 44 16 Acrocallosal syndrome, Al-gazali-bakalinova syndrome, Anorectal malformation, Cronkhite-canada syndrome, Greig cephalo-poly-syndactyly syndrome and 11 more
lung development
GO · q=8.76e-5
Cluster 45 16 Anastomosing hemangioma, Benign blood vessel neoplasm, Blue nevus, Capillary hemangioma, Capillary malformation and 11 more
Colorectal cancer
Pathway · q=2.51e-17
Cluster 46 16 Amyotrophic lateral sclerosis, susceptibility to, 24, Dilated cardiomyopathy 1V, Jeune syndrome, Jeune thoracic dystrophy, Joubert syndrome with ocular defect and 11 more
cilium assembly
GO · q=4.22e-35
Cluster 47 16 Anemia, congenital, non-spherocytic hemolytic, 9, Anemia, x-linked, Anemia, x-linked, with/without neutropenia and/or platelet abnormalities, Congenital erythropoietic porphyria, Cutaneous porphyria and 11 more
actin filament-based movement
GO · q=1.61e-3
Cluster 48 16 Ayme-gripp syndrome, Benign recurrent intrahepatic cholestasis, Cataract 21, multiple types, Cataract-multisystem syndrome, Cataract, pulverulent or cerulean, with or without microcornea and 11 more
AGE-RAGE signaling pathway in diabetic complications
Pathway · q=1.74e-18
Cluster 49 15 11p partial monosomy syndrome, Ambiguous genitalia, Anus neoplasms, Cataract 30, pulverulent, Congenital aniridia and 10 more
positive regulation of gene expression
GO · q=2.15e-5
Cluster 50 15 Apert syndrome, Cataract-intellectual disability-hypogonadism syndrome, Congenital malformation syndromes predominantly affecting facial appearance, Corpus callosum agenesis with facial anomalies and cerebellar ataxia, Craniofacial microsomia and 10 more
PI3K Cascade
Pathway · q=1.71e-5
Cluster 51 15 Agammaglobulinemia 6, autosomal recessive, Branchial arch abnormalities syndrome, Branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndrome, Branchial cleft anomalies, Congenital small ears and 10 more
cardiac septum morphogenesis
GO · q=1.79e-4
Cluster 52 15 Autosomal recessive primary microcephaly, Cerebellofaciodental syndrome, Congenital microcephaly, Diffuse cerebral and cerebellar atrophy-intractable seizures-progressive microcephaly syndrome, Ehlers-danlos syndrome, hypermobility type and 10 more
cell division
GO · q=1.72e-15
Cluster 53 15 Autosomal dominant oculodentodigital dysplasia, Bilateral microphthalmos, Erythrokeratodermia variabilis, Erythrokeratodermia variabilis et progressiva 2, Erythrokeratodermia variabilis et progressiva 3 and 10 more
Gap junction assembly
Pathway · q=2.26e-4
Cluster 54 15 Cerebellar atrophy with spinal motor neuronopathy, Cerebellar hypoplasia/atrophy, epilepsy, and global developmental delay, Ciliopathy-IFT74, Congenital brain malformation, Congenital hypoplasia of part of brain and 10 more
neuron migration
GO · q=2.14e-12
Cluster 55 15 Charcot-Marie-Tooth disease dominant intermediate E, Congenital nephrotic syndrome, Focal glomerulosclerosis, Focal segmental glomerulosclerosis, Hereditary steroid-resistant nephrotic syndrome and 10 more
AGE-RAGE signaling pathway in diabetic complications
Pathway · q=1.47e-10
Cluster 56 15 Autosomal dominant, spinal muscular atrophy, lower extremity-predominant, 2b, autosomal dominant, Axonal hereditary motor and sensory neuropathy, Cerebral cortical atrophy, Childhood-onset spinal muscular atrophy, Distal axonal motor neuropathy-myofibrillar myopathy syndrome and 10 more
Cytoskeleton in muscle cells
Pathway · q=2.27e-4
Cluster 57 15 Anophthalmia, Anophthalmia/microphthalmia-esophageal atresia syndrome, Colobomatous microphthalmia, Congenital cystic eyeball, Growth hormone deficiency with pituitary anomalies and 10 more
camera-type eye development
GO · q=6.88e-26
Cluster 58 15 Asymmetric septal hypertrophy, Biventricular noncompaction cardiomyopathy, Congenital myopathy 7a, myosin storage, autosomal dominant, Coronary stenosis, Dilated cardiomyopathy 1S and 10 more
cardiac muscle contraction
GO · q=8.16e-9
Cluster 59 15 Becker generalized myotonia, Congenital myopathy 22b, severe fetal, Congenital myotonia, Encephalopathy, acute, infection-induced, 3, Familial acute necrotizing encephalopathy and 10 more
monoatomic ion transmembrane transport
GO · q=2.23e-3
Cluster 60 15 Benign hypercalcemia, Calcium metabolism disorders, Familial isolated hyperparathyroidism, Hypercalcemia, Hypercalciuria and 10 more
Parathyroid hormone synthesis, secretion and action
Pathway · q=2.61e-17
Cluster 61 14 Autosomal recessive spinocerebellar ataxia 16, Cayman type cerebellar ataxia, Cerebellar ataxia, Neurodevelopmental disorder with motor abnormalities, seizures, and facial dysmorphism, Spastic ataxia and 9 more
Spinocerebellar ataxia
Pathway · q=1.03e-13
Cluster 62 14 Bachmann-bupp syndrome, Bladder papillary urothelial carcinoma, Dysplastic nevus, Epidermal nevus, Familial telangiectasia cancer syndrome and 9 more
Non-small cell lung cancer
Pathway · q=5.05e-19
Cluster 63 14 Breast fibrocystic disease, Congenital hernia of foramen of bochdalek, Cutis laxa, autosomal recessive, type id, Doyne honeycomb degeneration of retina, Doyne honeycomb retinal dystrophy and 9 more
ureteric bud development
GO · q=1.57e-5
Cluster 64 14 Anorexia nervosa, Cardiomyopathy, dilated, 2f, Charcot-Marie-Tooth disease, axonal, type 2FF, Early-onset distal myopathy, Eating disorder and 9 more
chemical synaptic transmission
GO · q=6.54e-6
Cluster 65 14 Bleeding disorder, platelet-type, 22, Carotid artery thrombosis, Glanzmann thrombasthenia, Hemorrhagic disease, Macrothrombocytopenia and 9 more
blood coagulation
GO · q=1.17e-40
Cluster 66 14 Angiomatoid fibrous histiocytoma, Askin tumor, Bone osteosarcoma, Cavernous hemangioma, Ectomesenchymoma and 9 more
Prostate cancer
Pathway · q=9.23e-12
Cluster 67 14 Aplastic anemia, Bone marrow failure syndromes, Diamond blackfan anemia with mandibulofacial dysostosis, Diamond-blackfan anemia, Dyskeratosis congenita and 9 more
SRP-dependent cotranslational protein targeting to membrane
Pathway · q=1.12e-32
Cluster 68 14 Atypical hemolytic uremic syndrome, Atypical hemolytic-uremic syndrome with anti-factor h antibodies, Atypical hemolytic-uremic syndrome with B factor anomaly, Atypical hemolytic-uremic syndrome with DGKE deficiency, C3 glomerulonephritis and 9 more
complement activation
GO · q=2.72e-18
Cluster 69 14 Aphasia, Cardiac tamponade, Commisural aphasia, Cutis laxa, autosomal dominant 1, Dejerine-lichtheim phenomenon and 9 more
positive regulation of chronic inflammatory response to antigenic stimulus
GO · q=5.59e-5
Cluster 70 14 Combined low ldl and fibrinogen, Congenital disorder of glycosylation, Congenital disorder of glycosylation type 1a, Congenital disorder of glycosylation type 1E, Congenital disorder of glycosylation type iii and 9 more
N-Glycan biosynthesis
Pathway · q=1.06e-45
Cluster 71 14 Amyotrophic lateral sclerosis type 6, Angiolipoma, Cutaneous fibrous histiocytoma, Epithelioid hemangioendothelioma, Giant cell tumor of soft tissue and 9 more
Prostate cancer
Pathway · q=8.78e-9
Cluster 72 14 Aniridia, Anterior segment dysgenesis, Anterior segment dysgenesis 4, Anterior segment dysgenesis 8, Anterior segment mesenchymal dysgenesis and 9 more
camera-type eye development
GO · q=4.36e-11
Cluster 73 14 Dilated cardiomyopathy 1A, Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome, Emery-dreifuss muscular dystrophy, Familial partial lipodystrophy type 2, Heart-hand syndrome, slovenian type and 9 more
Cytoskeleton in muscle cells
Pathway · q=6.81e-7
Cluster 74 14 Ataxia-hypogonadism-choroidal dystrophy syndrome, Beta-sarcoglycanopathy, Boucher-neuhauser syndrome, Brainstem atrophy, Cerebellar ataxia and hypogonadotropic hypogonadism and 9 more
N-glycan processing to lysosome
GO · q=1.86e-5
Cluster 75 14 B cell expansion with nfkb and t cell anergy (benta), autosomal dominant, B-cell expansion with nfkb and t-cell anergy, Benta disease, Cohen-gibson syndrome, Congenital cardiovascular anomaly and 9 more
facultative heterochromatin formation
GO · q=4.70e-6
Cluster 76 14 Brain-lung-thyroid syndrome, Choreatic disease, Choreoathetosis, hypothyroidism and neonatal respiratory distress, Hereditary progressive chorea without dementia, Immunodeficiency-centromeric instability-facial anomalies syndrome and 9 more
chromatin organization
GO · q=4.60e-5
Cluster 77 14 Benign kidney neoplasm, Benign renal pelvis neoplasm, Congenital mesoblastic nephroma, Cystic nephroma, Dopamine beta-hydroxylase deficiency and 9 more
positive regulation of cell migration
GO · q=7.32e-5
Cluster 78 14 Colorectal cancer, hereditary nonpolyposis, type 4, Colorectal cancer, hereditary nonpolyposis, type 5, Constitutional mismatch repair deficiency, Cystic leukoencephalopathy, Hereditary nonpolyposis colon cancer and 9 more
Colorectal cancer
Pathway · q=2.16e-14
Cluster 79 13 Abnormal corpus callosum, Armfield syndrome, Corpus callosum agenesis with intellectual disability, coloboma, micrognathia, Intellectual developmental disorder, x-linked, Intellectual disability, X-linked 106 and 8 more
modulation of chemical synaptic transmission
GO · q=3.62e-4
Cluster 80 13 Berardinelli-seip congenital lipodystrophy, Carotid intima-media thickness, Congenital generalized lipodystrophy, Epithelial ovarian carcinoma, Familial partial lipodystrophy and 8 more
Apoptosis
Pathway · q=5.98e-5
Cluster 81 13 Achondroplasia, Camptodactyly, tall stature, and hearing loss syndrome, Catshl syndrome, Cheilitis, Crouzon syndrome with acanthosis nigricans and 8 more
Bladder cancer
Pathway · q=5.44e-9
Cluster 82 13 Dominant dystrophic epidermolysis bullosa with absence of skin, Dominant dystrophic epidermolysis bullosa, albopapular type, Duane retraction syndrome, Dystrophic epidermolysis bullosa, Epidermolysis bullosa dystrophica inversa, autosomal recessive and 8 more
Parkinson disease
Pathway · q=3.91e-3
Cluster 83 13 Bronchiectasis, Bronchiectasis and nasal polyposis, Bronchiectasis with or without elevated sweat chloride 1, Bronchiectasis with or without elevated sweat chloride 2, Bronchiectasis with or without elevated sweat chloride 3 and 8 more
Aldosterone-regulated sodium reabsorption
Pathway · q=6.22e-8
Cluster 84 13 Aids, rapid progression to, Anhidrotic ectodermal dysplasia with immunodeficiency, osteopetrosis, and lymphedema, Autoinflammatory disease, systemic, x-linked, Bloch sulzberger syndrome, Congenital nonspherocytic hemolytic anemia and 8 more
Intestinal immune network for IgA production
Pathway · q=3.53e-7
Cluster 85 13 Cleft palate and bilateral cleft lip, Congenital cardiomyopathy, Leber hereditary optic neuropathy, Leber optic atrophy and dystonia, Melas syndrome and 8 more
proton motive force-driven mitochondrial ATP synthesis
GO · q=6.52e-16
Cluster 86 13 Albinism, Early-onset severe hermansky-pudlak syndrome with hearing loss, Hermansky-pudlak syndrome, Hermansky-pudlak syndrome 10, Hermansky-pudlak syndrome 11 and 8 more
platelet dense granule organization
GO · q=1.46e-20
Cluster 87 13 Albright hereditary osteodystrophy, Exocrine pancreatic carcinoma, Fibrous dysplasia, Macronodular adrenal hyperplasia, Mccune-albright syndrome and 8 more
Cushing syndrome
Pathway · q=1.60e-4
Cluster 88 13 Ichthyosis bullosa of siemens, Spastic paraplegia 70, autosomal recessive, Trichorrhexis nodosa syndrome, Trichothiodystrophy, Trichothiodystrophy 6, nonphotosensitive and 8 more
nucleotide-excision repair
GO · q=1.56e-15
Cluster 89 13 Autoinflammation, antibody deficiency, and immune dysregulation, Autosomal dominant sensorineural deafness, Cinca syndrome, Cold autoinflammatory syndrome, Cold urticaria, familial and 8 more
positive regulation of interleukin-1 beta production
GO · q=9.98e-4
Cluster 90 13 Blood coagulation disorder, Cerebral hemorrhage, Disseminated intravascular coagulation, Fetal erythroblastosis, Hemophilia a and 8 more
blood coagulation
GO · q=3.02e-46
Cluster 91 13 Carcinoid syndrome, Carney complex, Carney-stratakis syndrome, Cowden disease, Hereditary pheochromocytoma-paraganglioma and 8 more
mitochondrial electron transport, succinate to ubiquinone
GO · q=6.99e-11
Cluster 92 13 Arrhythmogenic cardiomyopathy with wooly hair and keratoderma, Cardiomyopathy, dilated, with woolly hair and keratoderma, autosomal recessive, Cardiomyopathy, dilated, with woolly hair, keratoderma, and tooth agenesis, Carvajal syndrome, Dilated cardiomyopathy with woolly hair, keratoderma, and tooth agenesis, autosomal dominant and 8 more
regulation of ventricular cardiac muscle cell action potential
GO · q=1.53e-6
Cluster 93 13 Cardiac valvular dysplasia, Congenital idiopathic intestinal pseudoobstruction, Congenital short bowel syndrome, Fg syndrome 2, Frontometaphyseal dysplasia and 8 more
GP1b-IX-V activation signalling
Pathway · q=8.64e-4
Cluster 94 13 Bifid nose, Bifid nose with or without anorectal and renal anomalies, Bnar syndrome, Craniofaciosynostosis, Encephalocraniocutaneous lipomatosis and 8 more
Melanoma
Pathway · q=2.56e-7
Cluster 95 12 Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease type 2D, Distal hereditary motor neuropathy, Distal spinal muscular atrophy, Motor neuron disease and 7 more
Amyotrophic lateral sclerosis
Pathway · q=8.56e-10
Cluster 96 12 15q13.3 microdeletion syndrome, Auditory perceptual disorder, Caudal regression syndrome, Congenital exomphalos, Congenital omphalocele and 7 more
establishment of planar polarity
GO · q=1.58e-7
Cluster 97 12 Anovulation, Congenital disorder of glycosylation, type iit, Dyslipidemias, Growth restriction, hypoplastic kidneys, alopecia, and distinctive facies, Hypercholesterolemia and 7 more
cholesterol homeostasis
GO · q=4.26e-26
Cluster 98 12 Aapoai amyloidosis, Amyloid polyneuropathy, Amyloidosis, 3 or more types, Apolipoprotein a-i amyloidosis, Apolipoprotein a-i and c-iii deficiency, combined and 7 more
Cholesterol metabolism
Pathway · q=1.48e-8
Cluster 99 12 Developmental delay with dysmorphic facies and brain anomalies, Hypomyelinating leukodystrophy, Hypomyelinating leukodystrophy 5, Hypomyelinating leukodystrophy 9, Leukodystrophy and 7 more
Cytosolic tRNA aminoacylation
Pathway · q=6.98e-8
Cluster 100 12 Abnormality of brain morphology, Acroosteolysis, Alagille syndrome, Benign smooth muscle neoplasm, Cervical carcinosarcoma and 7 more
Breast cancer
Pathway · q=1.44e-5
Cluster 101 12 Acanthoma, Congenital myopathy with excess of muscle spindles, Folliculitis, Non-neoplastic nevus, Penile neoplasms and 7 more
Endometrial cancer
Pathway · q=5.45e-8
Cluster 102 12 Aortic dissection, Arterial tortuosity syndrome, Cutaneous polyarteritis nodosa, Cutis laxa, autosomal recessive, type 1B, Deafness, autosomal dominant 56 and 7 more
positive regulation of extracellular matrix assembly
GO · q=1.63e-7
Cluster 103 12 Autoimmune disease, Autoimmune thyroid disease, Autoinflammation with pulmonary and cutaneous vasculitis, Celiac disease, Common variable immunodeficiency and 7 more
immune response
GO · q=6.98e-33
Cluster 104 12 Bestrophinopathy, Hemochromatosis, Hemochromatosis type 5, Iron metabolism disorder, Iron overload and 7 more
intracellular iron ion homeostasis
GO · q=1.75e-23
Cluster 105 12 Alexander disease, Combined psap deficiency, Combined saposin deficiency, Gaucher disease, Gaucher disease due to saposin C deficiency and 7 more
sensory perception of light stimulus
GO · q=2.45e-12
Cluster 106 12 Anhydramnios, Coronary restenosis, Diabetic cardiomyopathy, Fabry disease, Mental retardation, x-linked, syndromic, bain type and 7 more
kidney development
GO · q=6.70e-7
Cluster 107 12 Adie pupil, Autosomal dominant centronuclear myopathy, Congenital deformity of clavicle, Congenital deformity of elbow, Congenital deformity of forearm and 7 more
myelination
GO · q=1.22e-6
Cluster 108 12 Follicular thyroid cancer, Laryngeal carcinoma, Linear nevus sebaceous syndrome, Malignant adrenal gland pheochromocytoma, Malignant struma ovarii and 7 more
Thyroid cancer
Pathway · q=1.71e-12
Cluster 109 12 Afibrinogenemia, Amyloidosis, hereditary systemic 2, Congenital afibrinogenemia, Congenital brain dysgenesis due to glutamine synthetase deficiency, Congenital fibrinogen deficiency and 7 more
hemostasis
GO · q=2.52e-20
Cluster 110 12 Agranulocytosis, Bombay phenotype, Deficiency anemia, Infantile nephronophthisis and intellectual disability, Megaloblastic anemia and 7 more
Cobalamin (Cbl, vitamin B12) transport and metabolism
Pathway · q=2.37e-13
Cluster 111 12 Aicardi-goutieres syndrome 1, dominant and recessive, Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, Cerebroretinal vasculopathy, Chilblain lupus erythematosus, FANCM Fanconi-like genomic instability disorder and 7 more
regulation of metabolic process
GO · q=1.02e-3
Cluster 112 12 Bone fragility with contractures, arterial rupture, and deafness, Cole-carpenter syndrome, Craniotubular dysplasia, Dysostosis multiplex, ain-naz type, Immunoskeletal dysplasia with neurodevelopmental abnormalities and 7 more
collagen fibril organization
GO · q=7.79e-18
Cluster 113 12 Aldolase a deficiency, Danon disease, Dimauro disease, Exercise induced rhabdomyolysis, Glycogen phosphorylase kinase deficiency and 7 more
glycogen metabolic process
GO · q=4.77e-23
Cluster 114 12 Azoospermia, Congenital impairment of spermatozoa motility, Fanconi anemia complementation group V, Male infertility, Male infertility single gene azoospermia and 7 more
spermatogenesis
GO · q=1.64e-59
Cluster 115 12 Angiokeratoma, Blepharophimosis-ptosis-epicanthus inversus syndrome, Brain cancer, Brain neoplasms, Colon dysplasia and 7 more
Non-small cell lung cancer
Pathway · q=1.53e-10
Cluster 116 12 Anterior segment anomalies with or without cataract, Asymmetric crying face association, Bor syndrome, Branchiooculofacial syndrome, Branchiootic syndrome and 7 more
positive regulation of secondary heart field cardioblast proliferation
GO · q=1.85e-4
Cluster 117 12 Asplenia, Atrial septal defect 7, with or without av conduction defects, Congenital asplenia, Congenital septal defect of heart, Congenital-onset steinert myotonic dystrophy and 7 more
endocardial cushion development
GO · q=9.87e-6
Cluster 118 12 Bone mineral density quantitative trait locus, Camurati-engelmann syndrome, Delayed puberty, self-limited, Endosteal hyperostosis, worth type, Osteopetrosis and infantile neuroaxonal dystrophy and 7 more
Negative regulation of TCF-dependent signaling by WNT ligand antagonists
Pathway · q=4.28e-4
Cluster 119 12 Clouston syndrome, Deafness, autosomal dominant, 3b, Deafness, autosomal recessive 1b, Deafness, x-linked, Ectodermal dysplasia, hidrotic, autosomal dominant and 7 more
gap junction-mediated intercellular transport
GO · q=3.40e-4
Cluster 120 12 Breast-ovarian cancer, familial, susceptibility to, 4, Cancer predisposition, Fallopian tube serous adenocarcinoma, Familial ovarian cancer, Fanconi anemia complementation group j and 7 more
DNA repair
GO · q=6.86e-29
Cluster 121 12 Diffuse melanocytosis, Intradermal nevus, Lobular capilliary hemangioma, Mediastinum angiosarcoma, Melanocytic naevi and 7 more
Thyroid cancer
Pathway · q=2.13e-7
Cluster 122 11 17,20-lyase deficiency, Amenorrhea, Amyotrophic lateral sclerosis type 9, Bosch-boonstra-schaaf optic atrophy syndrome, Cataract-growth hormone deficiency-skeletal dysplasia syndrome and 6 more
Cortisol synthesis and secretion
Pathway · q=2.96e-9
Cluster 123 11 17q12 microdeletion syndrome, Bilateral multicystic dysplastic kidney, Cholestasis, Deafness, autosomal dominant 80, Giant cell tumor of tendon sheath and 6 more
pronephros development
GO · q=6.07e-8
Cluster 124 11 3-hydroxyisobutyric aciduria, Bladder calculus, Helix syndrome, Hyperuricemia, Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis and 6 more
urate metabolic process
GO · q=4.06e-6
Cluster 125 11 Alazami syndrome, Dwarfism, Ear, patella, short stature syndrome, Meier-gorlin syndrome, Meier-gorlin syndrome 2 and 6 more
DNA replication
GO · q=1.66e-20
Cluster 126 11 Berdon syndrome, Cystic fibrosis-related diabetes, Fetal megacystis, Intestinal obstruction, Intestinal pseudo-obstruction and 6 more
Smooth Muscle Contraction
Pathway · q=6.23e-6
Cluster 127 11 Acral self-healing collodion baby, Congenital ichthyosis, Congenital nonbullous ichthyosiform erythroderma, Ichthyosis, Ichthyosis prematurity syndrome and 6 more
Formation of the cornified envelope
Pathway · q=4.36e-9
Cluster 128 11 Acrocephalosyndactyly type v, Ankylosis, Antley-bixler syndrome without genital anomalies or disordered steroidogenesis, Biliary tract neoplasms, Congenital aural atresia and 6 more
Ras signaling pathway
Pathway · q=4.59e-5
Cluster 129 11 Asbestosis, Brachyphalangy, polydactyly and tibial aplasia syndrome, Cervical disc degenerative disorder, Gouty arthritis, Hepatolenticular degeneration and 6 more
Interleukin-4 and Interleukin-13 signaling
Pathway · q=3.61e-16
Cluster 130 11 Alstrom syndrome, Ataxia, spastic, autosomal dominant, Congenital myasthenic syndrome, Congenital myasthenic syndrome 8, Fetal akinesia deformation sequence and 6 more
synaptic transmission, cholinergic
GO · q=2.59e-10
Cluster 131 11 Congenital disorder of glycosylation type 1r, Epidermolysis bullosa, Epidermolysis bullosa simplex, Epileptic encephalopathy, early infantile, 49, Fructose-1,6-bisphosphatase deficiency and 6 more
Type I hemidesmosome assembly
Pathway · q=7.98e-22
Cluster 132 11 Glutamate pyruvate transaminase 2 deficiency, Hereditary spastic paraplegia, Hereditary spastic paraplegia 62, Spastic paraplegia, Spastic paraplegia 28, autosomal recessive and 6 more
vesicle-mediated transport
GO · q=8.38e-5
Cluster 133 11 Cobalamin c disease, Donnai-barrow syndrome, Intracellular cobalamin metabolism disorder, Methylmalonic acidemia, Methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency and 6 more
Cobalamin transport and metabolism
Pathway · q=4.71e-31
Cluster 134 11 Arterial occlusive disease, Asthenozoospermia, Brain edema, Cardiac injury, Cholesterol embolism and 6 more
response to hypoxia
GO · q=5.39e-5
Cluster 135 11 Bile acid malabsorption, Central nervous system disease, Choroidal neovascularization, Diabetes complications, Diabetes microvascular complications and 6 more
response to hypoxia
GO · q=7.69e-10
Cluster 136 11 Amnesia, Bradycardia, Catalepsy, Edema, Hyperalgesia and 6 more
Neuroactive ligand-receptor interaction
Pathway · q=1.06e-40
Cluster 137 11 Delayed sleep phase syndrome, Essential tremor, Intellectual disability with cerebellar atrophy, Movement disorder, Neurodevelopmental disorder with cerebellar atrophy and motor dysfunction and 6 more
response to amphetamine
GO · q=5.82e-6
Cluster 138 11 Body weight, Diabetes mellitus, Diabetic eye disease, Diabetic nephropathy type 2, Diabetic neuropathy and 6 more
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
GO · q=3.32e-11
Cluster 139 11 Deafness with congenital onychodystrophy, Deafness-onychodystrophy syndrome, Deafness, autosomal dominant 65, Deafness, autosomal recessive 86, Deafness, onychodystrophy, osteodystrophy, impaired intellectual development, and seizures syndrome and 6 more
Synaptic vesicle cycle
Pathway · q=1.63e-4
Cluster 140 11 Asthma, aspirin-induced, susceptibility to, Autosomal recessive limb-girdle muscular dystrophy, Congenital merosin-deficient muscular dystrophy, Limb-girdle muscular dystrophy, Muscular dystrophy and 6 more
Cytoskeleton in muscle cells
Pathway · q=5.74e-24
Cluster 141 11 Atrioventricular septal defect, Chromosome 8p23.1 monosomy, Congenital heart disease with or without pancreatic hypoplasia or diabetes, Congenital pulmonary valve atresia, Holt-oram syndrome and 6 more
atrioventricular canal development
GO · q=7.62e-6
Cluster 142 11 Colon inflammatory polyp, Congenital respiratory system anomaly, Eosinophilic leukemia, Gastrointestinal polyp, Gastrointestinal stromal tumor/gist-plus syndrome, somatic or familial and 6 more
face morphogenesis
GO · q=7.04e-6
Cluster 143 11 Cerebral venous sinus thrombosis, Congenital factor v deficiency, Diabetes macrovascular complications, East texas bleeding disorder, Factor v deficiency and 6 more
blood coagulation
GO · q=2.24e-5
Cluster 144 11 Ciliary dyskinesia, primary, 44, Deafness, autosomal dominant 73, Deafness, autosomal recessive 100, Deafness, autosomal recessive 107, Deafness, autosomal recessive 28 and 6 more
sensory perception of sound
GO · q=1.01e-2
Cluster 145 11 Jarcho-levin syndrome, Klippel-feil syndrome, Klippel-feil syndrome 2, Klippel-feil syndrome 4, autosomal recessive, with nemaline myopathy and facial dysmorphism, Leukodystrophy and acquired microcephaly with or without dystonia and 6 more
somite rostral/caudal axis specification
GO · q=2.08e-8
Cluster 146 10 17q21.31 microdeletion syndrome, Chromosome 17 deletion, Chromosome 17q21.31 deletion syndrome, Delayed psychomotor development, Dysgenesis of corpus callosum and 5 more
Stabilization of p53
Pathway · q=8.77e-4
Cluster 147 10 Amino acid metabolism disorder, Argininosuccinic aciduria, Cystathioninuria, Hyperammonemia, Lysinuric protein intolerance and 5 more
urea cycle
GO · q=3.60e-14
Cluster 148 10 46,xy gonadal dysgenesis, 46,xy partial gonadal dysgenesis, 46,xy sex reversal, 46xy sex reversal 6, Gonadal dysgenesis and 5 more
positive regulation of male gonad development
GO · q=3.43e-15
Cluster 149 10 Abnormality of limbs, Abnormality of the ear, Abnormality of the genitourinary system, Abnormality of the vertebrae, Abnormality of vision and 5 more
positive regulation of transcription elongation by RNA polymerase II
GO · q=4.82e-3
Cluster 150 10 Amyotrophic lateral sclerosis type 18, Autosomal recessive osteopetrosis 5, Bone disease, Bone fracture, Dupuytren contracture and 5 more
skeletal system development
GO · q=1.33e-13
Cluster 151 10 Annular epidermolytic ichthyosis, Congenital reticular ichthyosiform erythroderma, Diffuse nonepidermolytic palmoplantar keratoderma, Epidermolytic hyperkeratosis 1, Epidermolytic ichthyosis and 5 more
response to oxidative stress
GO · q=1.44e-7
Cluster 152 10 Accessory skin tag, Acrokeratosis verruciformis, Amyloidosis, hereditary systemic 4, finnish type, Autosomal recessive cutis laxa type 2B, Autosomal recessive cutis laxa type 2C and 5 more
elastic fiber assembly
GO · q=8.87e-10
Cluster 153 10 Adenomatous polyposis, Amyloidosis, hereditary systemic 1, Dystransthyretinemic euthyroidal hyperthyroxinemia, Familial adenomatous polyposis, Hyperthyroxinemia and 5 more
Displacement of DNA glycosylase by APEX1
Pathway · q=4.38e-4
Cluster 154 10 Corticosterone methyloxidase deficiency, Cushing syndrome, Familial hypoaldosteronism, Glucocorticoid-remediable aldosteronism, Hyperaldosteronism and 5 more
Cushing syndrome
Pathway · q=3.20e-10
Cluster 155 10 Cardiac anomalies - developmental delay - facial dysmorphism syndrome, Congenital camptodactyly, Developmental delay with facial dysmorphism syndrome, Discordant ventriculoarterial connection, Down syndrome and 5 more
Metabolism of folate and pterines
Pathway · q=1.61e-4
Cluster 156 10 Capillary-lymphatic-venous malformation, Congenital cleft hand, Congenital malformation syndromes predominantly involving limbs, Klippel-trenaunay syndrome, Microphthalmia with limb anomalies and 5 more
positive regulation of transcription by RNA polymerase II
GO · q=5.66e-7
Cluster 157 10 Aminoacylase deficiency, Baraitser-winter cerebrofrontofacial syndrome, Baraitser-winter syndrome 1, Becker nevus syndrome, Congenital smooth muscle hamartoma and 5 more
EPHB-mediated forward signaling
Pathway · q=8.88e-5
Cluster 158 10 Chiari-frommel syndrome, Delirium, Disruptive impulse-control and conduct disorder, Dyskinesia, Dyskinesia, drug-induced and 5 more
Hormone signaling
Pathway · q=1.36e-13
Cluster 159 10 Amyotrophic lateral sclerosis type 11, Bilateral parasagittal parieto-occipital polymicrogyria, Childhood-onset basal ganglia degeneration syndrome, Cleidocranial dysplasia with micrognathia, absent thumbs, and distal aphalangia (yunis-varon syndrome), Hypogonadotropic hypogonadism 1 with or without anosmia and 5 more
Prostate cancer
Pathway · q=4.94e-5
Cluster 160 10 Female infertility, Oocyte maturation defect, Oocyte/zygote/embryo maturation arrest 1, Oocyte/zygote/embryo maturation arrest 11, Oocyte/zygote/embryo maturation arrest 14 and 5 more
uterus development
GO · q=2.25e-8
Cluster 161 10 Chondroma, Combined d-2- and l-2-hydroxyglutaric aciduria, D-2-hydroxyglutaric aciduria, Gemistocytic astrocytoma, Hemangioma and 5 more
Central carbon metabolism in cancer
Pathway · q=2.59e-11
Cluster 162 10 Anemia, Atransferrinemia, Beta thalassemia, Congenital atransferrinemia, Congenital hypotransferrinemia and 5 more
multicellular organismal-level iron ion homeostasis
GO · q=1.22e-14
Cluster 163 10 Anti-glomerular basement membrane disease, Autoimmune hemolytic anemia, Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency, Berylliosis, Enteropathy and 5 more
Rheumatoid arthritis
Pathway · q=1.21e-8
Cluster 164 10 B-cell lymphopenia, Digit abnormalities, Hyperpituitarism, Hypocellular bone marrow, Hypogammaglobulinemia and 5 more
response to estrogen
GO · q=9.63e-4
Cluster 165 10 Bernard-soulier syndrome, Cerebral thrombosis, Hereditary von Willebrand disease, Intracranial thrombosis, Platelet-type bleeding disorder 8 and 5 more
blood coagulation
GO · q=6.84e-16
Cluster 166 10 Bone marrow failure, Fanconi anemia, Fanconi anemia complementation group e, Fanconi anemia complementation group f, Fanconi anemia complementation group g and 5 more
Fanconi anemia pathway
Pathway · q=7.25e-28
Cluster 167 10 Bronchopulmonary dysplasia, Chronic obstructive pulmonary disease, Cystic fibrosis, Immunodeficiency 97 with autoinflammation, Lung disease and 5 more
inflammatory response
GO · q=2.69e-24
Cluster 168 10 Blood vessel neoplasm, Conjunctival nevus, Familial multiple nevi flammei, Hemangioma of choroid, Malignant myoepithelioma and 5 more
Hepatocellular carcinoma
Pathway · q=1.10e-5
Cluster 169 10 Arthralgia, Bone marrow neoplasms, Exanthema, Hyper-igd syndrome, Hyper-immunoglobulin d syndrome and 5 more
isoprenoid biosynthetic process
GO · q=9.05e-4
Cluster 170 10 C5 deficiency, Cold paroxysmal hemoglobinuria, Developmental and epileptic encephalopathy, 55, Hemoglobinuria paroxysmal, Intellectual developmental disorder seizures dysmorphic skeletal and 5 more
Staphylococcus aureus infection
Pathway · q=1.37e-5
Cluster 171 10 Bart-pumphrey syndrome, Deafness, autosomal dominant 3a, Deafness, autosomal recessive 1a, Deafness, digenic, Hystrix-like ichthyosis with deafness and 5 more
cell communication
GO · q=3.21e-3
Cluster 172 10 Congenital hypothyroidism due to absence of thyroid gland, Congenital hypothyroidism non-goitrous type 2, Familial gestational hyperthyroidism, Hypothyroidism, congenital, non-goitrous, 1, Smith-lemli-opitz syndrome and 5 more
thyroid-stimulating hormone signaling pathway
GO · q=5.59e-5
Cluster 173 10 Clear cell sarcoma, Desmoplastic small round cell tumor, Extraskeletal myxoid chondrosarcoma, Malignant peripheral nerve sheath tumor, Malignant soft tissue neoplasm and 5 more
positive regulation of transcription by RNA polymerase II
GO · q=9.84e-28
Cluster 174 10 Kyphomelic dysplasia, Liver solitary fibrous tumor, Lung signet ring cell carcinoma, Lymphoepithelioma-like lung carcinoma, Lymphomatoid papulosis and 5 more
Non-small cell lung cancer
Pathway · q=4.01e-10
Cluster 175 10 Blue cone monochromatism, Colorblindness, partial, deutan series, Colorblindness, partial, protan series, Cone dystrophy, x-linked, Cone monochromatism and 5 more
absorption of visible light
GO · q=9.97e-12
Cluster 176 10 Deafness-lymphedema-leukemia syndrome, Dendritic cell, monocyte, b lymphocyte, and natural killer lymphocyte deficiency, Emberger syndrome, Gata2 deficiency, Leukemia, acute myeloid, susceptibility to and 5 more
negative regulation of cell growth
GO · q=5.95e-5
Cluster 177 10 Childhood ataxia with cns hypomyelination, Congenital or early infantile cach syndrome, Cree leukoencephalopathy, Leukoencephalopathy with vanishing white matter 1, Leukoencephalopathy with vanishing white matter 2 and 5 more
Recycling of eIF2:GDP
Pathway · q=1.95e-13
Cluster 178 10 Ciliary dyskinesia, primary, 38, Heterotaxy syndrome, Heterotaxy, visceral, 10, autosomal, with male infertility, Heterotaxy, visceral, 9, autosomal, with male infertility, Left-right axis malformations and 5 more
determination of left/right symmetry
GO · q=2.96e-21
Cluster 179 10 Complex spastic paraplegia, Cutis laxa, autosomal dominant 3, Cutis laxa, autosomal recessive, 3a, Cutis laxa, corneal clouding, and mental retardation, De barsy syndrome and 5 more
ornithine biosynthetic process
GO · q=3.19e-3
Cluster 180 10 Crash syndrome, Hydrocephalus due to aqueductal stenosis, L1 syndrome, Masa syndrome, Mental retardation-aphasia-shuffling gait-adducted thumbs syndrome and 5 more
Recycling pathway of L1
Pathway · q=7.11e-4
Cluster 181 10 Dilated cardiomyopathy 1G, Early-onset myopathy with fatal cardiomyopathy, Feingold syndrome, Hereditary myopathy with early respiratory failure, Myopathy, dominant-negative TTNsv and 5 more
skeletal muscle myosin thick filament assembly
GO · q=9.07e-3
Cluster 182 9 Complex cortical dysplasia with other brain malformations, Congenital fibrosis of extraocular muscles, Cortical development malformation, Cortical dysplasia with other brain malformations, Goldberg-Shprintzen syndrome and 4 more
microtubule cytoskeleton organization
GO · q=2.90e-15
Cluster 183 9 Angelman syndrome, Bruxism, CDKL5 disorder, Congenital retinal aneurysm, Congenital retinal anomaly and 4 more
synaptic transmission, GABAergic
GO · q=3.25e-5
Cluster 184 9 Carpal tunnel syndrome, Congenital cartilage disorder, Copper metabolism disorder, Osteochondrodysplasias, Spondyloepimetaphyseal dysplasia and 4 more
ECM proteoglycans
Pathway · q=4.06e-10
Cluster 185 9 17p11.2 microduplication syndrome, Birt-hogg-dube syndrome, Carcinoma of parotid gland, Omphalocele exstrophy imperforate anus, Pneumothorax and 4 more
negative regulation of glial cell proliferation
GO · q=1.97e-5
Cluster 186 9 Cleft lip, Cleft lip and palate, Cleft palate, Complete unilateral cleft lip, Craniosynostosis and 4 more
skeletal system development
GO · q=8.54e-16
Cluster 187 9 Bell's palsy, Brain injuries, Brain ischemia, Candidiasis, familial, 5, Colitis and 4 more
Lipid and atherosclerosis
Pathway · q=1.03e-25
Cluster 188 9 Autosomal systemic lupus erythematosus type 16, Candidiasis, familial, 6, Crest syndrome, Dermatomyositis, Diffuse cutaneous systemic sclerosis and 4 more
Inflammatory bowel disease
Pathway · q=1.40e-17
Cluster 189 9 Failure to thrive, Growth failure, Hepatic disease, Lowry-wood syndrome, Microcephalic osteodysplastic primordial dwarfism and 4 more
mRNA 5'-splice site recognition
GO · q=3.50e-3
Cluster 190 9 Abnormally shaped ears, Arched eyebrows, Deafness, autosomal dominant 20/26, Hearing loss, sensorineural, bilateral, progressive, Large mouth and 4 more
regulation of transepithelial transport
GO · q=5.22e-3
Cluster 191 9 Amyloidosis, Amyloidosis, hereditary systemic 6, Amyloidosis, primary localized cutaneous, 2, Apolipoprotein c-ii deficiency, Beta2-microglobulinic amyloidosis and 4 more
Amyloid fiber formation
Pathway · q=1.03e-10
Cluster 192 9 Ectodermal dysplasia, Ectodermal dysplasia 12, hypohidrotic/hair/tooth/nail type, Ectodermal dysplasia 13, hair/tooth type, Ectodermal dysplasia 15, hypohidrotic/hair type, Ectodermal dysplasia 4, hair/nail type and 4 more
hair follicle development
GO · q=4.24e-6
Cluster 193 9 Acral peeling skin syndrome, Erythema, Erythroderma, Exfoliative ichthyosis, ichthyosis bullosa of siemens-like, Hyperhidrosis and 4 more
Formation of the cornified envelope
Pathway · q=8.82e-4
Cluster 194 9 Calcifications in basal ganglia, Familial infantile myofibromatosis, Hypereosinophilic syndrome, Kosaki overgrowth syndrome, Myeloid neoplasm associated with pdgfrb rearrangement and 4 more
Constitutive Signaling by Aberrant PI3K in Cancer
Pathway · q=2.75e-5
Cluster 195 9 Angiofibroma, Appendix neuroendocrine tumor g1, Desmoid tumor, Desmoplastic fibroma, Intestinal neoplasms and 4 more
Endometrial cancer
Pathway · q=5.36e-15
Cluster 196 9 Creutzfeldt-jakob disease, Dementia in huntington's disease, Fatal familial insomnia, Gerstmann-straussler-scheinker syndrome, Kahrizi syndrome and 4 more
TRKA activation by NGF
Pathway · q=5.04e-4
Cluster 197 9 Adrenocortical carcinoma, Bile duct neoplasms, Diffuse midline glioma, Esophageal leukoplakia, Hepatoid adenocarcinoma and 4 more
Endometrial cancer
Pathway · q=2.94e-8
Cluster 198 9 Adrenocorticotropic hormone-producing pituitary gland carcinoma, Brain compression, Breast cyst, Large cell medulloblastoma, Pituitary adenoma 4, adrenocorticotropic hormone-secreting and 4 more
negative regulation of transcription by RNA polymerase II
GO · q=2.50e-3
Cluster 199 9 Cri-du-chat syndrome, Dyskeratosis congenita, autosomal dominant 2, Dyskeratosis congenita, autosomal recessive 4, Macrocytic anemia, Melanoma, cutaneous malignant, 9 and 4 more
Gastric cancer
Pathway · q=1.03e-3
Cluster 200 9 Agat deficiency, Arginine-glycine amidinotransferase deficiency, Bifunctional enzyme deficiency, D-bifunctional protein deficiency, De toni-debre-fanconi syndrome and 4 more
fatty acid beta-oxidation
GO · q=1.45e-6
Cluster 201 9 Anti-nmda receptor encephalitis, Joubert syndrome 3, Microscopic colitis, Selective iga deficiency disease, Selective immunoglobulin a deficiency and 4 more
Allograft rejection
Pathway · q=5.89e-6
Cluster 202 9 Bartter syndrome, Bartter syndrome, type 5, antenatal, transient, Gitelman syndrome, Hyperoxaluria, Hyperoxaluria primary 2 and 4 more
chloride transmembrane transport
GO · q=4.57e-12
Cluster 203 9 Albinism, black locks, cell migration disorder of the neurocytes of the gut, and deafness, Colonic aganglionosis, Deafness, autosomal recessive 8/10, Hirschsprung disease, susceptibility to, 2, Intestinal aganglionosis and 4 more
melanocyte differentiation
GO · q=1.97e-7
Cluster 204 9 Alpha-actinopathy, Congenital myopathy 2a, typical, autosomal dominant, Congenital myopathy 2b, severe infantile, autosomal recessive, Congenital myopathy 2c, severe infantile, autosomal dominant, Congenital myopathy 3 with rigid spine and 4 more
skeletal muscle fiber development
GO · q=4.47e-4
Cluster 205 9 Benign familial infantile convulsions, Coma, Early-onset dystonia with spastic paraplegia, Encephalopathy, Epileptic encephalopathy, early infantile, 82 and 4 more
olfactory cortex development
GO · q=6.91e-3
Cluster 206 9 Anaphylaxis, Anterior cruciate ligament injury, Bladder disease, Congenital high-molecular-weight kininogen deficiency, Extravasation of diagnostic and therapeutic materials and 4 more
inflammatory response
GO · q=1.51e-10
Cluster 207 9 Androgen insensitivity syndrome, Bladder clear cell adenocarcinoma, Bulbo-spinal atrophy, x-linked, Hypospadias 1, x-linked, Kennedy disease and 4 more
mitotic intra-S DNA damage checkpoint signaling
GO · q=7.72e-4
Cluster 208 9 Anemia, congenital, non-spherocytic hemolytic, 1, Anemia, nonspherocytic hemolytic, Chronic granulomatous disease, x-linked, G6PD deficiency, Granulomatous disease and 4 more
Cross-presentation of particulate exogenous antigens (phagosomes)
Pathway · q=1.01e-12
Cluster 209 9 Centronuclear myopathy, Congenital fiber type disproportion myopathy, Congenital myopathy, Congenital structural myopathy, Myopathy, centronuclear, 5 and 4 more
Cytoskeleton in muscle cells
Pathway · q=2.20e-18
Cluster 210 9 Anhedonia, Antisocial behavior, Antisocial personality disorder, Brunner syndrome, Dysthymic disorder and 4 more
cAMP signaling pathway
Pathway · q=1.68e-7
Cluster 211 9 Aplasia/hypoplasia of the corpus callosum, Cataract with late-onset corneal dystrohpy, Cataract-corneal dystrophy syndrome, Foveal hypoplasia, Foveal hypoplasia 1 and 4 more
signal transduction involved in regulation of gene expression
GO · q=3.42e-3
Cluster 212 9 Cervical clear cell adenocarcinoma, Developmental delay with immunodeficiency syndrome, Endocrine system disease, Growth retardation, Hepatic insufficiency and 4 more
Chemical carcinogenesis - reactive oxygen species
Pathway · q=2.13e-8
Cluster 213 9 Arachnoid cysts, Ciliary dyskinesia, primary, 42, Corpus callosum agenesis with abnormal genitalia, Epileptic encephalopathy early infantile type 1, Hydranencephaly with abnormal genitalia and 4 more
glycine receptor clustering
GO · q=6.11e-3
Cluster 214 9 Cardiofaciocutaneous syndrome, Congenital arteriovenous malformation, Costello syndrome, Fibromatosis, gingival, 1, Leopard syndrome and 4 more
Ras signaling pathway
Pathway · q=2.56e-18
Cluster 215 9 Arteriovenous hemangioma, Blue rubber bleb nevus syndrome, Bockenheimer syndrome, Congenital venous anomaly, Glomulovenous malformations and 4 more
Tie2 Signaling
Pathway · q=1.53e-5
Cluster 216 9 Asphyxiating thoracic dystrophy 5, Craniodiaphyseal dysplasia, Cranioectodermal dysplasia, Cranioectodermal dysplasia 1, Cranioectodermal dysplasia 4 and 4 more
intraciliary retrograde transport
GO · q=4.88e-14
Cluster 217 9 Benign carotid body paraganglioma, Chuvash erythrocytosis, Clear cell papillary cystadenoma, Endolymphatic sac tumor, Erythrocytosis due to tissue hypoxemia and 4 more
regulation of G1/S transition of mitotic cell cycle
GO · q=2.82e-3
Cluster 218 9 Baker-gordon syndrome, Dental enamel hypoplasia, Intellectual disability and central nervous system anomalies, Neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies, Pycnodysostosis and 4 more
odontogenesis
GO · q=2.67e-9
Cluster 219 9 Blepharophimosis syndrome, Blepharophimosis-intellectual disability syndrome, Genitopatellar syndrome, KAT6B-related disorders, Nicolaides-baraitser syndrome and 4 more
positive regulation of DNA-templated transcription
GO · q=7.05e-4
Cluster 220 9 Benign samaritan congenital myopathy, Central core disease, Congenital multicore myopathy with external ophthalmoplegia, Congenital myopathy 1a, autosomal dominant, with susceptibility to malignant hyperthermia, Congenital myopathy 1b, autosomal recessive and 4 more
cellular response to caffeine
GO · q=3.26e-5
Cluster 221 9 Bilateral frontoparietal polymicrogyria, Bilateral perisylvian polymicrogyria, Heparin cofactor 2 deficiency, Neurodevelopmental disorder with cardiomyopathy, spasticity, and brain abnormalities, Perisylvian syndrome and 4 more
Aggrephagy
Pathway · q=1.56e-4
Cluster 222 9 Cleft mandible, Clubfoot, Congenital clubfoot, Ehlers-danlos syndrome, musculocontractural type 1, Microtia and 4 more
olfactory nerve development
GO · q=4.47e-4
Cluster 223 9 Blastoma, Dicer1 syndrome, Global developmental delay, lung cysts, overgrowth, and wilms tumor, Glow syndrome, Goiter, multinodular 1, with or without sertoli-leydig cell tumors and 4 more
negative regulation of heart looping
GO · q=3.19e-3
Cluster 224 9 Ciliary dyskinesia, with or without situs inversus, Polynesian bronchiectasis, Primary ciliary dyskinesia 11, Primary ciliary dyskinesia 15, Primary ciliary dyskinesia 17 and 4 more
determination of left/right symmetry
GO · q=1.99e-14
Cluster 225 9 Brachyolmia, Brachyolmia type 4 with mild epiphyseal and metaphyseal changes, Brachyrachia, Congenital benign spinal muscular atrophy, Digital arthropathy-brachydactyly, familial and 4 more
regulation of calcium ion transmembrane transport via high voltage-gated calcium channel
GO · q=3.40e-4
Cluster 226 9 Cerebral embolism, Hypercalcemic tumoral calcinosis, Hyperphosphatemic familial tumoral calcinosis 2, Hyperphosphatemic tumoral calcinosis, Infertility and 4 more
FGFR1c and Klotho ligand binding and activation
Pathway · q=7.92e-5
Cluster 227 9 Cardioacrofacial dysplasia 1, Cardioacrofacial dysplasia 2, Cardiofacial dysplasia, Ellis-van creveld syndrome, Estrogen resistance and 4 more
Hedgehog signaling pathway
Pathway · q=2.79e-7
Cluster 228 9 Childhood myocerebrohepatopathy spectrum, Fanconi anemia complementation group i, Mitochondrial hepatopathy, Mitochondrial recessive ataxia syndrome (includes sando and scae), Neonatal convulsions and 4 more
mitochondrial DNA replication
GO · q=3.84e-4
Cluster 229 9 Chronic recurrent multifocal osteomyelitis 2, with periostitis and pustulosis, Dacryocystitis, Deficiency of interleukin-1 receptor antagonist, Ectodermal dysplasia and immunodeficiency 2, Interleukin 1 receptor antagonist deficiency and 4 more
Interleukin-1 signaling
Pathway · q=1.21e-4
Cluster 230 9 Dent disease, Hypophosphatemic rickets, Hypophosphatemic rickets, autosomal recessive, 1, Hypophosphatemic rickets, hereditary, with hypercalciuria, Oculocerebrorenal syndrome and 4 more
intracellular phosphate ion homeostasis
GO · q=1.38e-8
Cluster 231 9 Clear cell papillary renal cell carcinoma, Coloboma, osteopetrosis, microphthalmia, macrocephaly, albinism, and deafness, Commad syndrome, Melanoma, cutaneous malignant 8, Melanoma, cutaneous malignant, susceptibility to, 8 and 4 more
pigmentation
GO · q=1.59e-3
Cluster 232 9 Eye abnormalities, Frank-ter haar syndrome, Holoprosencephaly 3, Microphthalmia with coloboma 5, Neurodevelopmental disorder with severe motor impairment and absent language and 4 more
Pathways in cancer
Pathway · q=1.35e-5
Cluster 233 8 12q14 microdeletion syndrome, Buschke-ollendorff syndrome, Cardiofaciocutaneous syndrome 3, Dermatofibrosis lenticularis disseminata, Melorheostosis and 3 more
positive regulation of protein serine/threonine kinase activity
GO · q=7.90e-4
Cluster 234 8 14q11.2 microduplication syndrome, Autism, susceptibility to, 18, Chromodomain helicase dna binding protein 8 overgrowth syndrome, Congenital corneal opacity, Congenital ptosis and 3 more
brain development
GO · q=1.43e-4
Cluster 235 8 Chromosome 15q deletion syndrome, Congenital heart defects, Congenital heart disease, Conotruncal cardiac defect, Craniofacial abnormalities and 3 more
heart development
GO · q=1.65e-48
Cluster 236 8 Avoidant restrictive food intake disorder, Bile duct calculus, Carotid artery stenosis, Cavitary optic disc anomalies, Cavitary optic disk anomaly and 3 more
Degradation of the extracellular matrix
Pathway · q=8.18e-5
Cluster 237 8 Autosomal recessive spinocerebellar ataxia 2, Cerebelloparenchymal disorder, Lactic acidosis, Mitochondrial dna depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria), Normal pressure hydrocephalus and 3 more
establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis
GO · q=1.04e-2
Cluster 238 8 Holoprosencephaly, Holoprosencephaly 5, Holoprosencephaly-hypokinesia-congenital contractures syndrome, Microform holoprosencephaly, Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures and 3 more
determination of left/right symmetry
GO · q=7.65e-12
Cluster 239 8 Alport syndrome, Alport syndrome, x-linked, Digenic alport syndrome, Hearing loss, X-linked 6, Hematuria and 3 more
glomerular basement membrane development
GO · q=1.73e-7
Cluster 240 8 Congenital neutropenia, Immunodeficiency 76, Neutropenia, Neutropenia, nonimmune chronic idiopathic, adult, Severe congenital neutropenia and 3 more
SRP-dependent cotranslational protein targeting to membrane
GO · q=1.17e-7
Cluster 241 8 5-oxoprolinuria, Anemia, congenital, non-spherocytic hemolytic, 6, Enzyme disorder, Glutathione synthetase deficiency without 5-oxoprolinuria, Inherited glutathione synthetase deficiency and 3 more
DNA replication-dependent chromatin assembly
GO · q=9.20e-4
Cluster 242 8 Congenital communicating hydrocephalus, Congenital hydrocephalus, Cryptospermia, Hydrocephalus, Hydrocephalus, congenital, 2, with or without brain or eye anomalies and 3 more
neural tube closure
GO · q=1.73e-3
Cluster 243 8 Cardiac septal defects, Congenital malformations, Encephalopathy, acute, infection-induced, 5, herpes-specific, Hearing impairment, Herpes simplex encephalitis, susceptibility to, 3 and 3 more
ossification
GO · q=1.04e-2
Cluster 244 8 Abnormality of head or neck, Chromosome xq25 duplication syndrome, Clinodactyly of the 5th finger, Developmental delay with microcephaly and congenital anomalies, Growth delay and 3 more
spermidine metabolic process
GO · q=6.91e-3
Cluster 245 8 Abnormality of the face, Behavioral abnormality, Intellectual developmental disorder with short stature, facial anomalies, and speech delay, Morphological abnormality of the central nervous system, Neurodevelopmental disorder with dysmorphic facies, sleep disturbance, and brain abnormalities and 3 more
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay
GO · q=1.77e-3
Cluster 246 8 Abnormality of the genital system, Abnormality of the skin, Alopecia, Alopecia-intellectual disability syndrome, Amr syndrome and 3 more
triterpenoid biosynthetic process
GO · q=7.68e-3
Cluster 247 8 Benign paroxysmal torticollis of infancy, Epilepsy with myoclonic atonic seizures, Epileptic encephalopathy, early infantile, 6 (dravet syndrome), Familial hemiplegic migraine, Febrile seizures, familial, 3a and 3 more
transport across blood-brain barrier
GO · q=7.11e-4
Cluster 248 8 Aceruloplasminemia, Apoceruloplasmin deficiency, Ferroxidase deficiency, Hemochromatosis type 4, Hemosiderosis and 3 more
Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages)
Pathway · q=2.48e-6
Cluster 249 8 Anemia, congenital, non-spherocytic hemolytic, 5, Carbohydrate metabolism disease, Hexokinase deficiency, Intestinal disaccharide malabsorption, Neurodevelopmental disorder with visual defects and brain anomalies and 3 more
regulation of insulin secretion
GO · q=6.19e-6
Cluster 250 8 Achondrogenesis, Atelosteogenesis, Atelosteogenesis ii (includes clefting), De la chapelle dysplasia, Diastrophic dysplasia and 3 more
Collagen chain trimerization
Pathway · q=2.99e-3
Cluster 251 8 Atrophy, Ceroid lipofuscinosis, neuronal, 4a (kufs type), autosomal recessive, Dicarboxylic aminoaciduria, Leukoencephalopathy, motor delay, spasticity, and dysarthria syndrome, Neuronal ceroid lipofuscinosis and 3 more
negative regulation of neuron apoptotic process
GO · q=3.57e-12
Cluster 252 8 Atrophia bulborum heritaria, Coats disease, Exudative retinopathy, Exudative vitreoretinopathy, Exudative vitreoretinopathy 2, x-linked and 3 more
Norrin signaling pathway
GO · q=2.49e-9
Cluster 253 8 Acrodysostosis, Acrodysostosis 1, with or without hormone resistance, Atrial myxoma, Melanotic neurilemmoma, Oncocytic neoplasm and 3 more
positive regulation of cell differentiation
GO · q=8.36e-4
Cluster 254 8 Developmental and epileptic encephalopathy, 41, Dry eye syndrome, Hypotonia, infantile, with psychomotor retardation, Kawasaki disease, Myositis and 3 more
Inflammatory bowel disease
Pathway · q=1.12e-18
Cluster 255 8 Erythrocytosis, familial, 4, Gastrin-producing neuroendocrine tumor, Multiple endocrine neoplasia type 1, Multiple endocrine neoplasia type 4, Pancreatic glucagonoma and 3 more
Cushing syndrome
Pathway · q=3.70e-9
Cluster 256 8 Agammaglobulinemia 7, autosomal recessive, Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi, Diffuse idiopathic skeletal hyperostosis, Immunodeficiency 122, Immunodeficiency 36 with lymphoproliferation and 3 more
Thyroid hormone signaling pathway
Pathway · q=3.30e-4
Cluster 257 8 Adrenoleukodystrophy, Arthrogryposis multiplex congenita 3, myogenic type, Autosomal recessive ataxia, Dilated cardiomyopathy 2B, Heimler syndrome and 3 more
peroxisome organization
GO · q=7.89e-32
Cluster 258 8 Contiguous abcd1-dxs1375e deletion syndrome, Deafness, dystonia, and central hypomyelination with disorganization of the golgi apparatus, Deafness, dystonia, and cerebral hypomyelination, Encephalitis, Paraparesis and 3 more
Defective ABCD1 causes adrenoleukodystrophy (ALD)
Pathway · q=6.30e-3
Cluster 259 8 Exfoliation syndrome, Fuhrmann syndrome, Hypogonadotropic hypogonadism 14 with or without anosmia, Limb/pelvis-hypoplasia/aplasia syndrome, Skeletal malformations syndrome and 3 more
somatic stem cell division
GO · q=2.64e-3
Cluster 260 8 Agammaglobulinemia, Agammaglobulinemia 2, autosomal recessive, Agammaglobulinemia 3, autosomal recessive, Agammaglobulinemia 4, autosomal recessive, Autosomal agammaglobulinemia and 3 more
B cell differentiation
GO · q=1.48e-12
Cluster 261 8 Constipation, Diabetes insipidus, Eye pain, Nausea, Obesity, early-onset, with adrenal insufficiency and red hair and 3 more
positive regulation of chemokine production
GO · q=3.09e-5
Cluster 262 8 Arhinia-choanal atresia-microphthalmia syndrome, Bosma arhinia microphthalmia syndrome, Chediak-higashi syndrome, Facial nerve disorder, Facial palsy, congenital, with ptosis and velopharyngeal dysfunction and 3 more
dosage compensation by inactivation of X chromosome
GO · q=9.05e-4
Cluster 263 8 Becker muscular dystrophy, Benign congenital myopathy, Blepharoptosis, Clinodactyly, Duchenne muscular dystrophy and 3 more
Hedgehog 'off' state
Pathway · q=2.81e-5
Cluster 264 8 Bone neoplasms, Cerebrovascular trauma, Combined hyperlipidemia, familial, Connective tissue neoplasm, Coronary syndrome and 3 more
embryo implantation
GO · q=2.62e-3
Cluster 265 8 Autosomal recessive polycystic kidney disease, Biliary-renal-neuro-skeletal syndrome, Caroli disease, Congenital hypoplasia of aortic arch, Cystathionine beta-synthase deficiency and 3 more
animal organ morphogenesis
GO · q=1.08e-3
Cluster 266 8 Anonychia, Bent bone dysplasia, Campomelic dysplasia, Campomelic dysplasia with autosomal sex reversal, Cooks syndrome and 3 more
prostate gland morphogenesis
GO · q=7.47e-5
Cluster 267 8 Bullous pyoderma gangrenosum, Colchicine resistance, Familial mediterranean fever, Intermittent hydrarthrosis, Neutrophilic dermatosis, acute febrile and 3 more
G protein-coupled opioid receptor signaling pathway
GO · q=3.45e-4
Cluster 268 8 Hereditary hyperekplexia, Hyperekplexia, Hyperexplexia hereditary, Hyperexplexia, biallelic, Molybdenum cofactor deficiency with epileptic encephalopathy and cranial mri anomalies and 3 more
synaptic transmission, glycinergic
GO · q=6.71e-9
Cluster 269 8 Cerebral folate deficiency, Diabetic macular edema, Dias-logan syndrome, Intellectual developmental disorder hemoglobin persistence, Intellectual developmental disorder, autosomal dominant 45 and 3 more
bone trabecula morphogenesis
GO · q=1.08e-3
Cluster 270 8 Arterial calcification, generalized, of infancy, Arterial calcification, generalized, of infancy, 2, Desbuquois dysplasia, Dubin-johnson syndrome, Inherited pseudoxanthoma elasticum and 3 more
proteoglycan biosynthetic process
GO · q=1.38e-8
Cluster 271 8 Arterial calcification, generalized, of infancy, 1, Cole disease, Coronary medial sclerosis of infancy, Crystal arthropathy, Generalised arterial calcification of infancy and hypophosphatemic rickets and 3 more
negative regulation of hh target transcription factor activity
GO · q=5.22e-3
Cluster 272 8 Arteritis, Capillary leak syndrome, Central retinal vein occlusion, Congenital thrombotic thrombocytopenic purpura, Hereditary thrombophilia due to congenital protein C deficiency and 3 more
response to toxic substance
GO · q=2.93e-4
Cluster 273 8 Atrial septal defect with or without hypoplastic left heart syndrome, Atrioventricular excitation abnormality, Bile duct disease, Dilated cardiomyopathy 1EE, Glycogen storage disease of heart lethal congenital and 3 more
Oxytocin signaling pathway
Pathway · q=2.25e-4
Cluster 274 8 Atypical lobular breast hyperplasia, Bilateral cleft lip, Blepharocheilodontic syndrome, Cleft lip with or without cleft palate, Diffuse gastric and lobular breast cancer syndrome and 3 more
cell-cell adhesion mediated by cadherin
GO · q=2.60e-6
Cluster 275 8 Biliary atresia, Central hypoventilation syndrome, Congenital central hypoventilation syndrome, Haddad syndrome, Hirschsprung disease and 3 more
neural crest cell migration
GO · q=1.37e-12
Cluster 276 8 Bleeding disorder, Ehlers-danlos syndrome due to tenascin x deficiency, Ehlers-Danlos syndrome, classic type, Fibromuscular dysplasia, multifocal, Hermansky-pudlak syndrome 1 and 3 more
ECM proteoglycans
Pathway · q=5.02e-6
Cluster 277 8 Reducing body myopathy, Reducing body myopathy, x-linked 1a, severe, infantile or early childhood onset, Reducing body myopathy, x-linked 1b, with late childhood or adult onset, Uruguay faciocardiomusculoskeletal syndrome, X-linked emery-dreifuss muscular dystrophy and 3 more
muscle organ development
GO · q=5.31e-3
Cluster 278 8 Autoimmune disease, multisystem, infantile-onset, 1, Breast implant-associated anaplastic large cell lymphoma, Copper overload cirrhosis, Early-onset multisystem autoimmune disease, Hyper-immunoglobulin e recurrent infection syndrome 1, autosomal dominant and 3 more
Pathways in cancer
Pathway · q=7.57e-9
Cluster 279 8 Conjunctivitis, Dysplasminogenemia, Hypoplasminogenemia, Laryngeal disease, Leukocyte disorders and 3 more
Complement and coagulation cascades
Pathway · q=1.72e-2
Cluster 280 8 Autoimmune neurological syndrome, Charcot-Marie-Tooth disease type 2A2, Deafness, autosomal recessive 124, Epileptic encephalopathy, early infantile, 47, Lipomatosis, multiple symmetric, with or without peripheral neuropathy and 3 more
late endosome to vacuole transport via multivesicular body sorting pathway
GO · q=7.83e-3
Cluster 281 8 Autoinflammation with episodic fever and lymphadenopathy, Autoinflammation with infantile enterocolitis, Cria syndrome, Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infection syndrome, Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infection-lymphopenia syndrome and 3 more
interleukin-10-mediated signaling pathway
GO · q=7.98e-7
Cluster 282 8 Autoinflammation, panniculitis, and dermatosis syndrome, autosomal dominant, Autoinflammation, panniculitis, and dermatosis syndrome, autosomal recessive, Calcium pyrophosphate deposition, Chondrocalcinosis, Craniometadiaphyseal dysplasia and 3 more
microtubule-based transport
GO · q=6.11e-3
Cluster 283 8 Dysautonomia, Hereditary sensory and autonomic neuropathy, Hereditary sensory and autonomic neuropathy with spastic paraplegia, Hsan 1, Neuropathy, hereditary sensory and autonomic, type 1A and 3 more
sensory perception of pain
GO · q=4.01e-7
Cluster 284 8 Basal laminar drusen, Central serous retinopathy, Choroid diseases, Dense deposit disease, Factor h deficiency and 3 more
regulation of complement-dependent cytotoxicity
GO · q=7.09e-4
Cluster 285 8 Behavioral problems-intellectual disability-obesity-dysmorphic features syndrome, Chung-jansen syndrome, Developmental delay with intellectual disability and obesity, Dysmorphic facies, Hemorrhagic stroke and 3 more
regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling
GO · q=1.40e-2
Cluster 286 8 Congenital insensitivity to pain, Congenital pain insensitivity, Episodic pain syndrome, Erythromelalgia, Hereditary sensory and autonomic neuropathy type 4 and 3 more
sensory perception of pain
GO · q=5.40e-9
Cluster 287 8 Benign infantile epilepsy, Benign neonatal epilepsy, Benign neonatal-infantile seizures, Epilepsy of infancy with migrating focal seizures, Epileptic encephalopathy early infantile type 7 and 3 more
monoatomic ion transport
GO · q=1.21e-9
Cluster 288 8 Epilepsy with auditory features, Familial temporal lobe epilepsy, Lateral temporal lobe epilepsy, Lissencephaly 2 (norman-roberts type), Lissencephaly with cerebellar hypoplasia and 3 more
layer formation in cerebral cortex
GO · q=1.50e-3
Cluster 289 8 Chorioretinal atrophy, Deafness, aminoglycoside-induced, Deafness, nonsyndromic sensorineural, mitochondrial, Deafness, sensorineural, autosomal-mitochondrial type, External ophthalmoplegia and 3 more
Respiratory electron transport
Pathway · q=1.02e-3
Cluster 290 8 Biotinidase deficiency, Brachydactyly-syndactyly syndrome, Brachymesophalangy, Cryptorchidism, Ghosal hematodiaphyseal dysplasia and 3 more
face morphogenesis
GO · q=1.44e-5
Cluster 291 8 Congenital sensory neuropathy, Congenital sensory neuropathy with selective loss of small myelinated fibers, Corneal ulcer, Cyp2d6 deficiency, Periapical periodontitis and 3 more
nerve growth factor signaling pathway
GO · q=5.14e-7
Cluster 292 8 Boichis syndrome, Cerebellar malformation, Chylomicron retention disease, Joubert syndrome with hepatic defect, Meckel syndrome 3 and 3 more
lipid export from cell
GO · q=8.38e-3
Cluster 293 8 Heritable pulmonary arterial hypertension, Idiopathic pulmonary arterial hypertension, Pulmonary arterial hypertension, Pulmonary capillary hemangiomatosis, Pulmonary hypertension and 3 more
vasodilation
GO · q=5.43e-13
Cluster 294 8 Brain small vessel disease 1 with or without ocular anomalies, COL4A1-related disorder, Colpocephaly, Familial hematuria-retinal arteriolar tortuosity-contractures syndrome, Hereditary angiopathy with nephropathy, aneurysms, and muscle cramps and 3 more
renal tubule morphogenesis
GO · q=8.38e-3
Cluster 295 8 Bullous diffuse cutaneous mastocytosis, Embryonal carcinoma, Gingivitis, Hodgkin disease, Mastocytoma and 3 more
Lipid and atherosclerosis
Pathway · q=2.14e-6
Cluster 296 8 Carbamoyl phosphate synthetase deficiency, Congenital hyperammonemia, Congenital hypoplastic anemia, Developmental and epileptic encephalopathy, 50, Hypoplastic anemia and 3 more
'de novo' pyrimidine nucleobase biosynthetic process
GO · q=6.71e-9
Cluster 297 8 Metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression, Mitochondrial dna depletion syndrome, Mitochondrial myopathy, Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome, Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy and 3 more
mitochondrial DNA replication
GO · q=3.60e-16
Cluster 298 8 Cleft eyelid, Coloboma, Coloboma, ocular, autosomal recessive, Congenital iris coloboma, Congenital ocular coloboma and 3 more
camera-type eye development
GO · q=2.70e-8
Cluster 299 8 Epiphyseal chondrodysplasia, miura type, Familial focal epilepsy with variable foci, Focal epilepsy, Progressive myoclonic epilepsy, Progressive myoclonic epilepsy with renal failure and 3 more
regulation of protein localization to plasma membrane
GO · q=6.00e-4
Cluster 300 8 Chudley-mccullough syndrome, Elliptocytosis 1, Elliptocytosis 3, Hereditary elliptocytosis, Neonatal anemia and 3 more
'de novo' UMP biosynthetic process
GO · q=1.09e-7
Cluster 301 8 Colorectal cancer, hereditary nonpolyposis, type 7, Hereditary mixed polyposis syndrome, Intestinal polyposis, Juvenile polyp, Juvenile polypopsis syndrome, infantile form and 3 more
outflow tract septum morphogenesis
GO · q=1.31e-5
Cluster 302 8 Childhood-onset glut1 deficiency syndrome 2, Chromosome 17q23.1-q23.2 deletion syndrome, Dystonia 9 (paroxysmal choreoathetosis with episodic ataxia), Epilepsy with myoclonic absence, Glucose transporter type 1 deficiency syndrome and 3 more
Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1)
Pathway · q=2.65e-3
Cluster 303 8 Congenital sensorineural hearing loss, Deafness with congenital and adult-onset progressive leukodystrophy, Deafness, autosomal dominant 15, Deafness, autosomal recessive 3, Deafness, autosomal recessive 42 and 3 more
sensory perception of sound
GO · q=3.74e-5
Cluster 304 8 Deaf blind hypopigmentation syndrome, Pcwh syndrome, Peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, waardenburg syndrome, and hirschsprung disease, Waardenburg syndrome type 2e, Waardenburg syndrome type 4C and 3 more
positive regulation of gliogenesis
GO · q=3.19e-3
Cluster 305 8 Hypomyelinating leukodystrophy 2, Hypomyelinating leukodystrophy 3, Lymphedema, hereditary, ic, Pelizaeus-merzbacher disease, Spastic paraplegia 13, autosomal dominant and 3 more
central nervous system myelination
GO · q=7.04e-4
Cluster 306 7 Dopamine transporter deficiency syndrome, Mild cognitive impairment, Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures, Nicotine dependence, protection against, Paranoia and 2 more
monoamine transport
GO · q=1.16e-3
Cluster 307 7 17p13.3 microduplication syndrome, Chromosome 17p13.3 microdeletion syndrome, Clear cell sarcoma of kidney, Endometrial stromal sarcoma, Miller-dieker syndrome and 2 more
negative regulation of transcription by RNA polymerase II
GO · q=7.95e-3
Cluster 308 7 1p36.33 duplication syndrome, Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, Contracture, Disorder with global developmental delay, hypotonia, optic atrophy, axonal neuropathy, and hypertrophic cardiomyopathy, Harel-yoon syndrome and 2 more
mitochondrion organization
GO · q=5.81e-3
Cluster 309 7 Haim-munk syndrome, Paganini-miozzo syndrome, Papillon-lefevre syndrome, Periodontal disease, Periodontitis and 2 more
Arrhythmogenic right ventricular cardiomyopathy
Pathway · q=4.30e-4
Cluster 310 7 Encephalopathy, progressive, early-onset, with episodic rhabdomyolysis, Mucopolysaccharidosis, Mucopolysaccharidosis type 3B, Mucopolysaccharidosis type 3D, Mucopolysaccharidosis type iiib (sanfilippo b) and 2 more
Glycosaminoglycan degradation
Pathway · q=5.71e-24
Cluster 311 7 20p12.3 microdeletion syndrome, Hfe hemochromatosis, modifier of, Right ventricle hypoplasia, Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies, Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 1 and 2 more
positive regulation of osteoblast differentiation
GO · q=8.04e-4
Cluster 312 7 Chromosome 22q11.2 microduplication syndrome, Common arterial trunk with aortic dominance, Common arterial trunk with pulmonary dominance and interrupted aortic arch, Conotruncal anomaly face syndrome, Conotruncal heart malformations and 2 more
outflow tract septum morphogenesis
GO · q=8.88e-8
Cluster 313 7 2q37 microdeletion syndrome, Albright hereditary osteodystrophy type 3, Ataxia telangiectasia, Chromosome 2q37 deletion syndrome, Del(2)(q37) and 2 more
positive regulation of protein-containing complex assembly
GO · q=6.37e-6
Cluster 314 7 3-methylglutaconic aciduria, 3-methylglutaconic aciduria with deafness, encephalopathy, and leigh-like syndrome, Cognitive regression, Costeff syndrome, Dilated cardiomyopathy with ataxia and 2 more
protein import into mitochondrial matrix
GO · q=1.64e-3
Cluster 315 7 3p- syndrome (includes intellectual disability), Caveolinopathy, Chromosome 3p25 monosomy, Creatine phosphokinase elevation, Hyperckmia and 2 more
regulation of calcium ion transport
GO · q=2.02e-5
Cluster 316 7 46,xx ovotesticular disorder of sex development, 46,xx sex reversal, Gametogenic failure, Genetic panhypopituitarism, Panhypopituitarism, x-linked and 2 more
positive regulation of male gonad development
GO · q=7.98e-10
Cluster 317 7 46xy sex reversal 3, Adrenal insufficiency, Autoimmunity, Disorder of sex development, Immunodeficiency 126, susceptibility to and 2 more
luteinization
GO · q=6.72e-4
Cluster 318 7 46xy sex reversal 9, Congenital diaphragmatic hernia, Diaphragmatic hernia 5, x-linked, Diaphragmatic malformations, Osteoporosis with fractures and 2 more
metanephros development
GO · q=1.49e-5
Cluster 319 7 Chagas cardiomyopathy, Cousin syndrome, Craniofacial dysmorphism, hypoplasia of scapula and pelvis, and short stature (cousin syndrome), Growth disorder, Neurodevelopmental disorder with language delay and seizures and 2 more
insulin-like growth factor receptor signaling pathway
GO · q=2.87e-3
Cluster 320 7 Biliary cholangitis, Biliary cirrhosis, Inner ear disease, Liver cirrhosis, Liver disease and 2 more
immune response
GO · q=8.05e-21
Cluster 321 7 Abnormal cortical gyration, Cortical occipital malformations, Developmental delay with language impairment and movement disorder, Intellectual developmental disorder autism speech, Intellectual developmental disorder speech autism dysmorphic and 2 more
general adaptation syndrome
GO · q=7.68e-3
Cluster 322 7 Charcot-Marie-Tooth disease axonal type 2CC, Conjunctival disease, Giant axonal neuropathy, Non-neoplastic peripheral nervous system disease, Peripheral nervous system disease and 2 more
neurofilament bundle assembly
GO · q=1.05e-4
Cluster 323 7 Abnormality of movement, Axial hypotonia, Neurodevelopmental disorder with hypotonia and autistic features with or without hyperkinetic movements, Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements, Neurodevelopmental disorder with spasticity, cataracts, and cerebellar hypoplasia and 2 more
Presynaptic depolarization and calcium channel opening
Pathway · q=4.62e-4
Cluster 324 7 Abnormality of the cerebellum, Abnormality of the foot, Epileptic encephalopathy, early infantile, 66, Generalized hypotonia, Hypoplasia of the corpus callosum and 2 more
synaptic vesicle endocytosis
GO · q=5.15e-3
Cluster 325 7 Abnormality of the eye, Basilicata-akhtar syndrome, Central hypotonia, Hypotonia, hypoventilation, impaired intellectual development, dysautonomia, epilepsy, and eye abnormalities, Hypoventilation and 2 more
AMP biosynthetic process
GO · q=1.79e-2
Cluster 326 7 Antecubital pterygium syndrome, Genitourinary disease, Hengel maroofian schols syndrome, Malunion fracture, Neurodevelopmental disorder with thinning of corpus callosum and cerebellar atrophy and 2 more
neuron recognition
GO · q=3.20e-3
Cluster 327 7 Acne inversa, Acne inversa, familial, 3, Alzheimer disease, type 3, with spastic paraparesis and apraxia, Early onset alzheimers disease with behavioral disturbance, Parkinson disease 8, autosomal dominant and 2 more
Noncanonical activation of NOTCH3
Pathway · q=1.60e-7
Cluster 328 7 Brachydactyly, Multiple synostoses syndrome, Primary ovarian insufficiency, Proximal symphalangism, Stapes ankylosis with broad thumb and toes and 2 more
chondrocyte differentiation
GO · q=4.29e-9
Cluster 329 7 Angioedema, Angioedema induced by ace inhibitors, Angioneurotic edema, hereditary, with normal c1 inhibitor concentration and function, Congenital factor xii deficiency, Factor xii deficiency and 2 more
Complement and coagulation cascades
Pathway · q=6.14e-7
Cluster 330 7 Acromegaloid facial appearance syndrome, Cantu syndrome, Dilated cardiomyopathy 1O, Hypertrichosis, Hypertrichotic osteochondrodysplasia Cantu type and 2 more
ATP sensitive Potassium channels
Pathway · q=6.70e-7
Cluster 331 7 Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome, Deafness, mitochondrial, modifier of, Episodes of liver failure, peripheral neuropathy, cerebellar atrophy, and ataxia, Infantile liver failure, Infantile-onset recurrent acute liver failure and skeletal abnormalities and 2 more
retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum
GO · q=1.58e-3
Cluster 332 7 Advanced sleep phase syndrome, Cobalamin metabolism disorder, Homocystinuria with megaloblastic anemia, Homocystinuria, cbld type, variant 1, Inborn disorder of cobalamin metabolism and transport and 2 more
cobalamin metabolic process
GO · q=5.56e-7
Cluster 333 7 Arboleda-tham syndrome, Deafness, autosomal recessive 29, Intellectual disability with craniofacial anomalies and cardiac defects, Mental retardation, autosomal dominant 32, Papillary hidradenoma and 2 more
Prostate cancer
Pathway · q=1.46e-6
Cluster 334 7 B-cell non-hodgkin lymphoma, Congenital disorder of glycosylation type II, Follicular lymphoma, Lymphoma, Marginal zone lymphoma and 2 more
Pathways in cancer
Pathway · q=5.71e-24
Cluster 335 7 Alcoholic hepatitis, Angina pectoris, Autoimmune uveitis, Cachexia, Chondromalacia and 2 more
positive regulation of smooth muscle cell proliferation
GO · q=2.39e-7
Cluster 336 7 Alpha thalassemia, Alpha thalassemia spectrum, Erythrocytosis, familial, 7, Heinz body anemias, alpha, Hemoglobin barts fetalis syndrome and 2 more
nitric oxide transport
GO · q=1.97e-5
Cluster 337 7 Alpha-1 antitrypsin deficiency, Beriberi, Emphysema-cirrhosis, Gastro-entero-pancreatic neuroendocrine tumor, Immunodeficiency 63 with lymphoproliferation and autoimmunity and 2 more
Th1 and Th2 cell differentiation
Pathway · q=1.35e-4
Cluster 338 7 Arthrogryposis multiplex congenita, Arthrogryposis multiplex congenita 1, neurogenic, with myelin defect, Arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum, Neuromuscular disorder, congenital, with dysmorphic facies, Pena-shokeir syndrome and 2 more
Striated Muscle Contraction
Pathway · q=3.44e-7
Cluster 339 7 Bethlem myopathy, Collagen 6-related myopathy, Collagen vi muscular dystrophy, Collagen vi-related myopathy, Dystonia 27 and 2 more
Collagen chain trimerization
Pathway · q=7.11e-14
Cluster 340 7 Alport syndrome 3a, autosomal dominant, Alport syndrome 3b, autosomal recessive, Congenital hearing disorder, Deafness, autosomal dominant 76, Hematuria, benign familial and 2 more
sensory perception of sound
GO · q=9.64e-4
Cluster 341 7 Cutaneous mastocytosis, Glutamate formiminotransferase deficiency, Intellectual developmental disorder growth seizures, Isovaleric acidemia, Mastocytosis and 2 more
ERBB4 signaling pathway
GO · q=3.21e-3
Cluster 342 7 Alzahrani-kuwahara syndrome, Desanto-shinawi syndrome, Dysmorphism, lens dislocation, anterior segment abnormalities, and filtering blebs, Facial dysmorphism syndrome, Facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome and 2 more
ventral midline development
GO · q=1.85e-4
Cluster 343 7 Binge eating disorder, Congenital stenosis of aortic valve, Familial hypobetalipoproteinemia 1, Hypercholesterolemia, autosomal dominant, type B, Hypobetalipoproteinemia and 2 more
cholesterol metabolic process
GO · q=8.26e-5
Cluster 344 7 Atrial and intestinal dysrhythmia, Chronobiology disorder, Hyperoxia, Patent ductus venosus, Pruritus and 2 more
Neuroactive ligand-receptor interaction
Pathway · q=2.52e-6
Cluster 345 7 Ciliary dyskinesia, primary, 54, Frontotemporal dementia, Frontotemporal dementia and/or amyotrophic lateral sclerosis 5, Frontotemporal dementia and/or amyotrophic lateral sclerosis 7, Frontotemporal dementia with motor neuron disease and 2 more
Amyotrophic lateral sclerosis
Pathway · q=2.06e-10
Cluster 346 7 Amyotrophic lateral sclerosis 26 with or without frontotemporal dementia, Frontotemporal dementia and/or amyotrophic lateral sclerosis 3, Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset, Paget disease, Paget disease of bone 3 and 2 more
Osteoclast differentiation
Pathway · q=6.96e-4
Cluster 347 7 Deafness, autosomal dominant 37, Fibrochondrogenesis, Fibrochondrogenesis 1, Intervertebral disc displacement, Mitochondrial dna depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria) and 2 more
succinyl-CoA pathway
GO · q=1.15e-2
Cluster 348 7 Anemia, sideroblastic, 2, pyridoxine-refractory, Erythropoietic protoporphyria, Linear skin defects with multiple congenital anomalies 3, Pyridoxine refractory sideroblastic anemia 2, Sideroblastic anemia and 2 more
iron-sulfur cluster assembly
GO · q=1.82e-6
Cluster 349 7 Aneurysmal bone cyst, Malignant triton tumor, Pleural sarcomatoid mesothelioma, Pleural solitary fibrous tumor, Plexiform neurofibroma and 2 more
Non-small cell lung cancer
Pathway · q=1.14e-5
Cluster 350 7 Cavernous malformations of cns, Cerebral cavernous malformation, Congenital cerebral aneurysm, Congenital malformation of cerebral vessels, Developmental venous anomaly and 2 more
endothelium development
GO · q=3.78e-6
Cluster 351 7 Anorexia, Congestive ophthalmopathy, Graft-versus-host disease, Granulomatosis with polyangiitis, Graves ophthalmopathy and 2 more
immune response
GO · q=6.86e-15
Cluster 352 7 Anodontia, Craniofacial dysplasia - osteopenia syndrome, Frontonasal dysplasia, Frontonasal dysplasia, severe microphthalmia, severe facial clefting syndrome, Hamamy syndrome and 2 more
embryonic skeletal system morphogenesis
GO · q=2.06e-6
Cluster 353 7 Ap-4 deficiency syndrome, Cerebral palsy, Cerebral palsy, spastic quadriplegic 2, Cerebral palsy, spastic quadriplegic 3, Intellectual disability and spastic paraplegia and 2 more
Lysosome Vesicle Biogenesis
Pathway · q=3.99e-4
Cluster 354 7 Arts syndrome, Ataxia with deafness and vision loss, Myopathy, distal, 7, adult-onset, x-linked, Phosphoribosylpyrophosphate synthetase superactivity, PRPS1 deficiency disorder and 2 more
subthalamic nucleus development
GO · q=6.11e-3
Cluster 355 7 Aortic valve disease 3, Bicuspid aortic valve, Congenital erythroderma with palmoplantar keratoderma, hypotrichosis, and hyper-ige, Diffuse palmoplantar keratoderma, Focal palmoplantar keratoderma with joint keratoses and 2 more
aortic valve morphogenesis
GO · q=4.61e-6
Cluster 356 7 Deafness, autosomal dominant, 78, Delpire-mcneill syndrome, Intestinal malrotation, Kilquist syndrome, Lymphatic system disease and 2 more
establishment or maintenance of epithelial cell apical/basal polarity
GO · q=2.19e-3
Cluster 357 7 Bilirubin metabolism disease, Crigler-najjar syndrome, Gilbert syndrome, Hyperbilirubinemia, Lucey-driscoll syndrome and 2 more
negative regulation of fatty acid metabolic process
GO · q=7.68e-22
Cluster 358 7 Ciliary dyskinesia, primary, 41, Immunodeficiency, common variable, 12, Nasal disorder, Nasal polyp, Pharyngeal disorder and 2 more
Inflammatory bowel disease
Pathway · q=3.62e-11
Cluster 359 7 Arthrogryposis, Escobar syndrome, Hypo-akinesia disorder of prenatal onset, Multiple pterygium syndrome, escobar variant, Multiple pterygium syndrome, lethal type and 2 more
skeletal muscle contraction
GO · q=1.48e-9
Cluster 360 7 Asperger syndrome, Behavior disorders, Epileptic encephalopathy with global cerebral demyelination, Epileptic encephalopathy, early infantile, 39, Fatigue syndrome and 2 more
positive regulation of cell-matrix adhesion
GO · q=8.25e-3
Cluster 361 7 Body mass index, Diastolic heart failure, Growth retardation, developmental delay, and facial dysmorphism, Growth retardation, developmental delay, coarse facies, and early death, Lethal polymalformative syndrome, boissel type and 2 more
adenylate cyclase-activating G protein-coupled receptor signaling pathway
GO · q=8.54e-4
Cluster 362 7 Atrophoderma vermiculata, Burnett schwartz berberian syndrome, Common migraine, Keratosis follicularis spinulosa decalvans, Keratosis pilaris atrophicans and 2 more
positive regulation of lysosomal protein catabolic process
GO · q=2.47e-4
Cluster 363 7 Auricle malformation, Diamond-blackfan anemia 6, Erythroid hypoplasia, Hypoplastic thumb, Ovarian agenesis and 2 more
metanephric S-shaped body morphogenesis
GO · q=3.50e-4
Cluster 364 7 Autoimmune lymphoproliferative disorder, Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 2A, Immunodeficiency 64, Lymphoproliferative syndrome and 2 more
FasL/ CD95L signaling
Pathway · q=8.41e-9
Cluster 365 7 Greenberg dysplasia, Hydrops-ectopic calcification-moth-eaten skeletal dysplasia, Mesomelia, Pelger-huet anomaly, Regressive spondylometaphyseal dysplasia and 2 more
Regulation of MECP2 expression and activity
Pathway · q=1.07e-2
Cluster 366 7 Congenital muscular dystrophy, Congenital muscular dystrophy due to dystroglycanopathy, Muscle eye brain disease, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a13 and 2 more
Mannose type O-glycan biosynthesis
Pathway · q=3.09e-23
Cluster 367 7 Digenic hemochromatosis, Hemochromatosis type 1, Hemochromatosis type 3, Mannose-binding protein deficiency, Polymyalgia rheumatica and 2 more
multicellular organismal-level iron ion homeostasis
GO · q=7.64e-8
Cluster 368 7 Beta-ureidopropionase deficiency, Cryptogenic west syndrome, Epileptic encephalopathy, early infantile, 84, Infantile spasms, Medium chain acyl-coa dehydrogenase deficiency and 2 more
action potential
GO · q=5.75e-6
Cluster 369 7 Brain small vessel disease, Cerebral small vessel disease, Congenital porencephaly, Intracerebral hemorrhage, Porencephaly 2 and 2 more
menaquinone catabolic process
GO · q=9.05e-4
Cluster 370 7 Birk-barel syndrome, Cataract 50 with or without glaucoma, Cataract-glaucoma syndrome, Mulibrey nanism, Neurodevelopmental disorder with hypotonia, dysmorphic facies, and skeletal anomalies, with or without seizures and 2 more
regulation of interleukin-1 production
GO · q=1.40e-2
Cluster 371 7 Cerebellar diseases, Intellectual developmental disorder microcephaly cerebellar, Mental retardation and microcephaly with pontine and cerebellar hypoplasia, Mental retardation, with or without nystagmus, Mowat-wilson syndrome and 2 more
hindbrain development
GO · q=1.23e-3
Cluster 372 7 Cerebrofacioarticular syndrome, Chromosome 16p13.3 deletion syndrome, Hennekam lymphangiectasia-lymphedema syndrome 1, Hennekam lymphangiectasia-lymphedema syndrome 2, Hennekam lymphangiectasia-lymphedema syndrome 3 and 2 more
N-terminal peptidyl-lysine acetylation
GO · q=2.75e-5
Cluster 373 7 Brain atrophy, Neurodegeneration, childhood-onset, with progressive microcephaly, Neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity, Neurodevelopmental disorder with or without structural brain anomalies, optic atrophy, seizures and spasticity, Neurodevelopmental disorder with seizures and brain atrophy and 2 more
protein transmembrane transport
GO · q=2.46e-3
Cluster 374 7 Breast ductal adenoma, Breast fibrosis, Fanconi anemia complementation group D2, Intraductal breast papilloma, Overgrowth syndrome and 2 more
Endocrine resistance
Pathway · q=8.56e-14
Cluster 375 7 Camptocormia, Chronic progressive external ophthalmoplegia, Mitochondrial dna depletion syndrome 8a (encephalomyopathic type with renal tubulopathy), Progressive external ophthalmoplegia with mitochondrial dna deletions (autosomal dominant), Progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 5 and 2 more
mitochondrial DNA replication
GO · q=2.14e-4
Cluster 376 7 Fraser syndrome, Intellectual developmental disorder with cardiac arrhythmia, Language delay and adhd/cognitive impairment with or without cardiac arrhythmia, Lodder-merla syndrome, type 1, with impaired intellectual development and cardiac arrhythmia, Lodder-merla syndrome, type 2, with developmental delay and with or without cardiac arrhythmia and 2 more
pyruvate import into mitochondria
GO · q=2.20e-4
Cluster 377 7 Codas syndrome, Encephalopahty, lethal, due to defective mitochondrial peroxisomal fission, Encephalopathy due to mitochondrial and peroxisomal fission defect, Fatal encephalopathy, lactic acidosis, and severe mitochondrial dna depletion in muscle, Mitochondrial encephalomyopathy and 2 more
Respiratory electron transport
Pathway · q=1.46e-4
Cluster 378 7 Congenital digestive system anomaly, Ectodermal dysplasia 17 with or without limb malformations, H syndrome, Histiocytosis-lymphadenopathy plus syndrome, Multiple endocrine neoplasia type 2A and 2 more
Thyroid cancer
Pathway · q=9.86e-8
Cluster 379 7 Congenital malrotation of intestine, Desmosterolosis, Hydrops fetalis, Lymphatic malformation, Mucopolysaccharidosis type 7 and 2 more
Tie2 Signaling
Pathway · q=1.52e-4
Cluster 380 7 Cervical dystonia, Developmental delay, leukoencephalopathy, and neurologic decompensation, Dystonia 1, torsion, autosomal dominant, Dystonic disorder, Early-onset generalized limb-onset dystonia and 2 more
Inhibition of PKR
Pathway · q=7.09e-3
Cluster 381 7 Childhood-onset dystonia, Childhood-onset dystonia with optic atrophy and basal ganglia abnormalities, Coffin-lowry syndrome, Complex early-onset dystonia, Developmental delay with behavioral abnormalities and 2 more
ERBB signaling pathway
GO · q=2.39e-4
Cluster 382 7 Chloracne, Heinz body anemias, Hemoglobin m disease, Methemoglobinemia, Rapid progression to aids from hiv1 infection and 2 more
carbon dioxide transport
GO · q=8.90e-9
Cluster 383 7 Cholestasis, neonatal intrahepatic, caused by citrin deficiency, Citrin deficiency, Citrullinemia, Citrullinemia type 2, adult onset, Citrullinemia type 2, neonatal onset and 2 more
Urea cycle
Pathway · q=6.68e-5
Cluster 384 7 Chronic infantile diarrhea due to guanylate cyclase 2c overactivity, Congenital chloride diarrhea, Congenital secretory diarrhea, Congenital sodium diarrhea, Duodenal atresia and 2 more
Mineral absorption
Pathway · q=6.55e-3
Cluster 385 7 Familial hypercholesterolemia, Gallbladder disease, Hypercholesterolemia, autosomal dominant, 3, Hypercholesterolemia, familial, 1, Ldl cholesterol level qtl2 and 2 more
intestinal cholesterol absorption
GO · q=2.95e-6
Cluster 386 7 Complex hereditary spastic paraplegia, Complicated spastic paraparesis, Spastic paraplegia 23, autosomal recessive, Spastic paraplegia 26, autosomal recessive, Spastic paraplegia 45, autosomal recessive and 2 more
Glycosphingolipid metabolism
Pathway · q=5.26e-3
Cluster 387 7 Congenital adrenal hyperplasia due to 21-hydroxylase deficiency, Cortisone reductase deficiency, Hyper-immunoglobulin e syndrome 4a, autosomal dominant, with recurrent infections, Hyper-immunoglobulin e syndrome 4b, autosomal recessive, with recurrent infections, Hyperandrogenism and 2 more
leukemia inhibitory factor signaling pathway
GO · q=1.21e-4
Cluster 388 7 Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay, Congenital hypoplasia of kidney, Focal segmental glomerulosclerosis 7, Nephrotic syndrome, focal segmental type, Papillorenal syndrome and 2 more
branching involved in ureteric bud morphogenesis
GO · q=3.30e-6
Cluster 389 7 Congenital lymphatic dysplasia with hydrops and/or lymphedema, Dehydrated hereditary stomatocytosis 1 with or without pseudohyperkalemia and/or perinatal edema, Dehydrated hereditary stomatocytosis 2, Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema, Hereditary xerocytosis and 2 more
monoatomic ion transport
GO · q=1.67e-3
Cluster 390 7 Hyperuricemic nephropathy, Juvenile hyperuricemic nephropathy, Polycystic liver disease 2, SEC61A1 deficiency, Tubulo-interstitial and glomerulocystic kidney disease with anemia and 2 more
juxtaglomerular apparatus development
GO · q=9.35e-5
Cluster 391 7 Dysmorphic facial features, Intellectual developmental disorder, autosomal dominant 70, Luscan-lumish syndrome, Microcephaly-severe intellectual disability-multiple congenital anomalies syndrome, Neurodevelopmental disorder without or with macrocephaly/overgrowth and 2 more
regulation of protein localization to chromatin
GO · q=4.26e-3
Cluster 392 7 Early-onset epilepsy, Epileptic encephalopathy, early infantile, 56, Mental retardation, autosomal dominant 13, Neuronal migration abnormalities, Severe intellectual disability with neuronal migration disorder and 2 more
Loss of Nlp from mitotic centrosomes
Pathway · q=7.32e-4
Cluster 393 7 Epstein syndrome, Fechtner syndrome, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Macrothrombocytopenia and progressive sensorineural deafness, May-hegglin anomaly and 2 more
organic acid metabolic process
GO · q=2.26e-4
Cluster 394 6 Beckwith-wiedemann syndrome, Hemihyperplasia, Pregnancy disorder, Silver-russell syndrome, Silver-russell syndrome 3 and 1 more
insulin-like growth factor receptor signaling pathway
GO · q=1.08e-5
Cluster 395 6 15q24 microdeletion, Cardiac malformation, cleft lip/palate, microcephaly, and digital anomalies, Cardiac, facial, and digital anomalies with developmental delay, Cleft palate cardiac defects impaired intellectual development, Cleft palate congenital heart defect intellectual disability syndrome due to 15q14 microdeletion and 1 more
response to methylglyoxal
GO · q=4.26e-3
Cluster 396 6 Adult myoclonic epilepsy, Benign adult familial myoclonic epilepsy, Benign myoclonic epilepsy, Epileptic encephalopathy, early infantile, 78, Familial adult myoclonic epilepsy and 1 more
monoatomic ion transmembrane transport
GO · q=1.62e-6
Cluster 397 6 1p21.3 microdeletion syndrome, Anal polyp, Dihydropyrimidinase deficiency, Dihydropyrimidine dehydrogenase deficiency, Dihydropyrimidine metabolism disorder and 1 more
uracil catabolic process
GO · q=1.86e-5
Cluster 398 6 Chromosome 2p16.3 deletion syndrome, Cortical dysplasia-focal epilepsy syndrome, Internet addiction disorder, Language development disorders, Neurodevelopmental disorder with absent speech and movement and behavioral abnormalities and 1 more
adult behavior
GO · q=1.79e-7
Cluster 399 6 Abruzzo-erickson syndrome, Cleft palate with ankyloglossia, Cleft palate x-linked, Neurodevelopmental disorder with achalasia, polyneuropathy, and alacrima, Uranostaphyloschisis and 1 more
positive regulation of neuron migration
GO · q=4.78e-3
Cluster 400 6 Bronchus cancer, Choriocarcinoma of ovary, Coumarin resistance, Fanconi anemia complementation group D1, Radio-tartaglia syndrome and 1 more
establishment of protein localization to telomere
GO · q=2.26e-4
Cluster 401 6 2,8-dihydroxyadenine urolithiasis, Adenine phosphoribosyltransferase deficiency, Encephalopathy associated with multiple oxidative phosphorylation complex deficiencies and a mitochondrial translation defect, End stage renal disease, Interstitial nephritis and 1 more
adenine salvage
GO · q=6.91e-3
Cluster 402 6 3mc syndrome, 3mc syndrome 1, Carnevale syndrome, Craniofacial ulnar renal syndrome, Malpuech facial clefting syndrome and 1 more
Lectin pathway of complement activation
Pathway · q=7.62e-7
Cluster 403 6 Gastric tubular adenocarcinoma, Hidradenocarcinoma, Intellectual developmental disorder dysmorphic microcephaly, Intellectual developmental disorder growth microcephaly, Intellectual developmental disorder, autosomal dominant 21 and 1 more
Pathways in cancer
Pathway · q=9.12e-6
Cluster 404 6 Abeta amyloidosis, Amyloid angiopathy, Amyloid neuropathy, Cerebral amyloid angiopathy, dutch, italian, iowa, flemish, arctic variants, Eye manifestations and 1 more
astrocyte activation involved in immune response
GO · q=1.28e-5
Cluster 405 6 Ablepharon macrostomia syndrome, Barber-say syndrome, Congenital ectodermal dysplasia of face, Focal facial dermal dysplasia, Focal facial dermal dysplasia 3, setleis type (can include intellectual disability and developmental delay) and 1 more
Defective CYP26C1 causes Focal facial dermal dysplasia 4 (FFDD4)
Pathway · q=3.64e-3
Cluster 406 6 Abnormal brain imaging, Axonal neuropathy, Hypotonia, Intellectual developmental disorder speech peripheral neuropathy, Kyphosis and 1 more
ubiquitin-dependent protein catabolic process via the C-end degron rule pathway
GO · q=9.05e-4
Cluster 407 6 Congenital anomalies of the kidney and urinary tract, Microcephaly, facial dysmorphism, renal agenesis, and ambiguous genitalia syndrome, Neurodevelopmental disorder with or without urinary tract abnormalities, Renal agenesis, Renal dysplasia, cystic, susceptibility to and 1 more
kidney development
GO · q=1.00e-18
Cluster 408 6 Abnormal muscle tone, Beukes hip dysplasia, Developmental delay and epilepsy, Lack of speech, Neurodevelopmental disorder with microcephaly, movement abnormalities, and seizures and 1 more
spermidine metabolic process
GO · q=5.22e-3
Cluster 409 6 Hepatic veno occlusive disease with immunodeficiency, Immunodeficiency 32b, monocyte and dendritic cell deficiency, autosomal recessive, Lymphocytic b-cell leukemia, Lymphocytic leukemia, Lymphoid leukemia and 1 more
apoptotic process
GO · q=4.77e-8
Cluster 410 6 Abnormality of the cardiovascular system, Abnormality of the cerebrum, Abnormality of the skeletal system, Craniofacial neurological cardiovascular and skeletal features (turnpenny-fry syndrome), Turnpenny-fry syndrome and 1 more
negative regulation of type B pancreatic cell apoptotic process
GO · q=3.88e-4
Cluster 411 6 Cerebellar hypoplasia, Cerebellar, ocular, craniofacial, and genital syndrome, Cerebello-oculo-facio-genital syndrome, Congenital labioscrotal agenesis-cerebellar malformation-corneal dystrophy-facial dysmorphism syndrome, Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations and 1 more
glycoprotein transport
GO · q=1.53e-2
Cluster 412 6 Aplasia cutis congenita, Epidermolysa bullosa simplex and limb girdle muscular dystrophy, Epidermolysis bullosa simplex 5c, with pyloric atresia, Epidermolysis bullosa simplex 5d, generalized intermediate, autosomal recessive, Muscular dystrophy-epidermolysis bullosa simplex spectrum disorder and 1 more
Type I hemidesmosome assembly
Pathway · q=4.47e-15
Cluster 413 6 Acid-base disorder, Amed syndrome, Blepharitis, Laryngeal neoplasms, Respiratory system neoplasm and 1 more
Ethanol oxidation
Pathway · q=5.25e-8
Cluster 414 6 Acinar prostate adenocarcinoma, foamy gland variant, Acinar prostate mucinous adenocarcinoma, Benign prostatic hyperplasia, Cervical polyp, Megabladder, congenital and 1 more
positive regulation of transcription by RNA polymerase II
GO · q=5.90e-9
Cluster 415 6 Acoustic neuroma, Cellular schwannoma, Loss of heterozygosity neurofibromatosis, type 2, Lymphoplasmacyte-rich meningioma, Meningioma, nf2-related, somatic and 1 more
regulation of gliogenesis
GO · q=3.19e-3
Cluster 416 6 Camptosynpolydactyly, Gollop-wolfgang complex, Mesoaxial synostotic syndactyly with phalangeal reduction, malik-percin type, Metacarpal 4-5 fusion, Syndactyly and 1 more
embryonic digit morphogenesis
GO · q=3.75e-10
Cluster 417 6 Acromesomelic dysplasia, Chronic myeloid leukemia, Hematologic malignancy predisposition syndrome, Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to, Premature ovarian insufficiency and 1 more
chondrocyte differentiation
GO · q=3.39e-6
Cluster 418 6 Activated pi3k-delta syndrome, Combined immunodeficiency with facio-oculo-skeletal anomalies, Immunodeficiency 14, Immunodeficiency 14a, autosomal dominant, Immunodeficiency 14b, autosomal recessive and 1 more
Synthesis of PIPs at the plasma membrane
Pathway · q=5.31e-5
Cluster 419 6 Acute hepatic porphyria, Hepatoerythropoietic porphyria, Lead poisoning, susceptibility to, Porphyria, Porphyria cutanea tarda and 1 more
heme B biosynthetic process
GO · q=3.65e-25
Cluster 420 6 Acute lymphoblastic leukemia, Dna ligase iv deficiency, Dubowitz syndrome, Lig4 syndrome, Severe combined immunodeficiency autosomal recessive t-cell-negative/b-cell-negative/nk-cell-positive with sensitivity to ionizing radiation and 1 more
Non-homologous end-joining
Pathway · q=1.28e-6
Cluster 421 6 Continuous spike and wave during sleep syndrome, Continuous spike and wave during slow wave sleep syndrome, Epilepsy with neurodevelopmental defects, Focal epilepsy with speech disorder and impaired intellectual development, Gastric mantle cell lymphoma and 1 more
animal organ regeneration
GO · q=9.58e-4
Cluster 422 6 Adenosine deaminase 2 deficiency, Developmental disorder with delayed myelination and seizures, Polyarteritis nodosa, Sneddon syndrome, Vasculitis and 1 more
negative regulation of myeloid cell differentiation
GO · q=2.17e-4
Cluster 423 6 Adenosine kinase deficiency, Glycine n-methyltransferase deficiency, Hepatic methionine adenosyltransferase deficiency, Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase, S-adenosylhomocysteine hydrolase deficiency and 1 more
one-carbon metabolic process
GO · q=9.48e-7
Cluster 424 6 Adrenal adenoma, Adrenal cortex neoplasm, Aldosterone-producing adenoma, Andersen-tawil syndrome, Familial hyperaldosteronism type III and 1 more
Aldosterone synthesis and secretion
Pathway · q=2.09e-8
Cluster 425 6 Agammaglobulinemia and isolated hormone deficiency, Borderline ovarian serous tumor, Bruton type agammaglobulinemia, X-linked agammaglobulinemia, X-linked agammaglobulinemia with growth hormone deficiency and 1 more
Endometrial cancer
Pathway · q=2.06e-13
Cluster 426 6 Cerebral creatine deficiency syndrome, Creatine deficiency, Creatine transporter deficiency, Gamt deficiency, Guanidinoacetate methyltransferase deficiency and 1 more
creatine metabolic process
GO · q=1.57e-9
Cluster 427 6 Agnathia-holoprosencephaly-situs inversus syndrome, Butterfly-shaped pigmentary macular dystrophy, Ectopic posterior pituitary, Microphthalmia, syndromic 5, Patterned macular dystrophy and 1 more
response to low light intensity stimulus
GO · q=6.11e-3
Cluster 428 6 Aica-ribosiduria, Bladder inflammatory myofibroblastic tumor, Inflammatory myofibroblastic tumor, Liver inflammatory myofibroblastic tumor, Microcephaly, developmental delay, and brittle hair and nails and 1 more
Longevity regulating pathway
Pathway · q=5.42e-7
Cluster 429 6 Aicardi goutieres syndrome, Deoxyguanosine kinase deficiency, Interferonopathy, Progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive 4, RNU7-1-related type 1 interferonopathy and 1 more
mismatch repair
GO · q=3.82e-7
Cluster 430 6 Aicardi-goutieres syndrome associated with a type i interferon signature, Cancer, alopecia, pigment dyscrasia, onychodystrophy, and keratoderma, Dyschromatosis, Dyschromatosis symmetrica hereditaria, Dyschromatosis universalis hereditaria 1 and 1 more
cellular detoxification of cadmium ion
GO · q=1.69e-4
Cluster 431 6 Blau syndrome, Bronchiolitis obliterans, Granulomatous inflammatory arthritis-dermatitis-uveitis, familial, Intestinal disease, Intestinal dysmotility syndrome and 1 more
positive regulation of interleukin-8 production
GO · q=4.78e-5
Cluster 432 6 Autosomal recessive mental retardation, Li-campeau syndrome, Mental retardation, autosomal recessive 27, Mental retardation, autosomal recessive 39, Neurodevelopmental disorder with progressive movement abnormalities and 1 more
positive regulation of smoothened signaling pathway
GO · q=1.25e-2
Cluster 433 6 Alkuraya-kucinskas syndrome, Brain atrophy, dandy walker and contractures, Congenital hemivertebra, Ficus syndrome, Micrognathism and 1 more
cartilage development
GO · q=1.60e-4
Cluster 434 6 Hypotrichosis, Hypotrichosis 6, Hypotrichosis simplex, Woolly hair, Woolly hair autosomal recessive 2 and 1 more
Formation of the cornified envelope
Pathway · q=6.68e-5
Cluster 435 6 Alport syndrome with mental retardation midface hypoplasia and elliptocytosis, Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome, Amme complex, Fraxe intellectual disability, Midface hypoplasia-hearing impairment-elliptocytosis-nephrocalcinosis syndrome and 1 more
negative regulation of prostaglandin secretion
GO · q=9.07e-3
Cluster 436 6 Epiphyseal dysplasia, Epiphyseal dysplasia, multiple, 3, with or without myopathy, Laryngeal hypoplasia, Marshall syndrome, Myopia 28, autosomal recessive and 1 more
Collagen biosynthesis and modifying enzymes
Pathway · q=4.44e-14
Cluster 437 6 Alternating hemiplegia of childhood, Capos syndrome, Cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss, Congenital epicanthus, Neurological disorder and 1 more
potassium ion transport
GO · q=2.15e-5
Cluster 438 6 Eye neoplasms, Oculocutaneous albinism, Oculocutaneous albinism type 4, Oculocutaneous albinism type 6, Prader-willi syndrome and 1 more
melanin biosynthetic process
GO · q=5.81e-14
Cluster 439 6 Amegakaryocytic thrombocytopenia, Congenital amegakaryocytic thrombocytopenia, Myelofibrosis with myeloid metaplasia, Thrombocythemia, Thrombocythemia with distal limb defects and 1 more
thrombopoietin-mediated signaling pathway
GO · q=5.93e-11
Cluster 440 6 Amelogenesis imperfecta, Dentin dysplasia, Dentin dysplasia with microdontia and misshapen teeth, Dentinogenesis imperfecta, Enamel-renal syndrome and 1 more
biomineral tissue development
GO · q=9.66e-17
Cluster 441 6 Macular telangiectasia, Neu-laxova syndrome, Neurometabolic disorder, Phosphoserine phosphatase deficiency, Spastic paraplegia 77, autosomal recessive and 1 more
L-serine biosynthetic process
GO · q=2.91e-6
Cluster 442 6 Chromosome 10q deletion syndrome, Developmental delay with ataxia, hypotonia, and facial dysmorphism, Developmental regression, Hepatoencephalopathy due to combined oxidative phosphorylation defect, Hypotonia, ataxia, and delayed development syndrome and 1 more
Complex I biogenesis
Pathway · q=1.07e-4
Cluster 443 6 Congenital nemaline myopathy, Nemaline myopathy, Nemaline myopathy 10, Nemaline myopathy 7, Nemaline myopathy 8 and 1 more
Cytoskeleton in muscle cells
Pathway · q=4.15e-12
Cluster 444 6 Epilepsy and intellectual disability, Fetal growth restriction, Intellectual developmental disorder, autosomal dominant 56, Mental retardation, autosomal dominant 56, Ovarian steroid cell tumor and 1 more
Defective DHDDS causes retinitis pigmentosa 59
Pathway · q=1.73e-5
Cluster 445 6 Corneal astigmatism, Diaphanospondylodysostosis, Glaucoma, Neurodevelopmental disorder, nonprogressive, with spasticity and transient opisthotonus, Obsolete glaucoma 1, open angle, F and 1 more
positive regulation of transcription by RNA polymerase II
GO · q=3.92e-8
Cluster 446 6 Autoimmune pancreatitis, Autosomal recessive osteopetrosis 3, Carbonic anhydrase deficiency, Cholangitis, Hyperammonemic encephalopathy and 1 more
positive regulation of hormone biosynthetic process
GO · q=1.53e-4
Cluster 447 6 Asthma, Eczema, Keratoderma, palmoplantar, nagashima type, Neurodevelopmental disorder with congenital malformations, Obstructive pulmonary disease and 1 more
Inflammatory bowel disease
Pathway · q=1.46e-25
Cluster 448 6 Angiofollicular ganglionic hyperplasia, Angiolymphoid hyperplasia, Castleman disease, Congenital microtia, Headache and 1 more
response to glucocorticoid
GO · q=2.93e-4
Cluster 449 6 Brain disease, Cognition disorder, Delirium, dementia, and cognitive disorders, Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 7, Encephalopathy, acute, infection-induced, susceptibility to, 6 and 1 more
negative regulation of gene expression
GO · q=1.71e-8
Cluster 450 6 Anhidrotic ectodermal dysplasia, Christ-siemens-touraine syndrome, Craniofrontonasal dysplasia, Neurodevelopmental disorders, X-linked hypohidrotic ectodermal dysplasia and 1 more
TNFs bind their physiological receptors
Pathway · q=1.58e-7
Cluster 451 6 Ectodermal dysplasia 3, witkop type, Neurodegeneration, childhood-onset, with multisystem involvement due to mitochondrial dysfunction, Tooth agenesis, selective, 1, Tooth and nail syndrome, Witkop syndrome and 1 more
odontogenesis
GO · q=3.04e-3
Cluster 452 6 Autosomal dominant polycystic kidney disease, Gillessen-kaesbach-nishimura syndrome, Polycystic kidney disease, Polycystic kidney disease 3 with or without polycystic liver disease, Polycystic liver disease and 1 more
kidney development
GO · q=1.41e-12
Cluster 453 6 Aortic rupture, Au-kline syndrome, Menkes disease, Neuronopathy, distal hereditary motor, x-linked, Occipital horn syndrome and 1 more
Degradation of the extracellular matrix
Pathway · q=1.90e-4
Cluster 454 6 Cardiomyopathy, dilated, 2k, Juvenile arthritis, Juvenile idiopathic arthritis, Oligoarticular juvenile idiopathic arthritis, Polyarticular juvenile idiopathic arthritis and 1 more
Th17 cell differentiation
Pathway · q=7.35e-12
Cluster 455 6 Cerebellar vermis atrophy, Cerebral arteriovenous malformations, Epistaxis, Hereditary hemorrhagic telangiectasia, Neurodevelopmental disorder with microcephaly, ataxia, and seizures and 1 more
positive regulation of peptidyl-serine phosphorylation
GO · q=3.10e-6
Cluster 456 6 Deafness, autosomal dominant 1, Deafness, autosomal dominant 1, with or without thrombocytopenia, Hearing loss, autosomal recessive 116, Pendred syndrome, Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome and 1 more
sensory perception of sound
GO · q=2.11e-5
Cluster 457 6 Arylsulfatase a deficiency, Mucopolysaccharidosis type 6, Mucopolysaccharidosis type vi (maroteaux-lamy), Mucopolysaccharidosis vi (mps6), Multiple sulfatase deficiency and 1 more
The activation of arylsulfatases
Pathway · q=1.07e-4
Cluster 458 6 Ascending aortic dilation, Congenital finger flexion contractures, Congenital musculoskeletal anomalies, Failure to thrive in infancy, Generalized joint laxity and 1 more
cardiac muscle cell proliferation
GO · q=4.13e-8
Cluster 459 6 Ataxia and seizures, Ataxia, spastic, autosomal recessive, Early-onset spastic ataxia-myoclonic epilepsy-neuropathy syndrome, Optic atrophy and/or spastic ataxia spectrum, Spastic ataxia optic atrophy dysarthria syndrome and 1 more
membrane docking
GO · q=7.68e-3
Cluster 460 6 Decreased nerve conduction velocities, Distal sensory loss, Hereditary ataxia, Hyporeflexia, Neurodegeneration, childhood-onset, with cerebellar atrophy and 1 more
adult walking behavior
GO · q=3.93e-3
Cluster 461 6 Autism, susceptibility to, x-linked 6 (includes intellectual disability), Autism, x-linked, Bulbar palsy, Central apnea, Encephalopathy, neonatal severe and 1 more
social behavior
GO · q=1.10e-6
Cluster 462 6 Graves disease, Hashimoto disease, Hyperthyroidism, Okt4 epitope deficiency, Thyroid disease and 1 more
Autoimmune thyroid disease
Pathway · q=5.03e-23
Cluster 463 6 Autoinflammation, lipodystrophy, and dermatosis syndrome, Candle syndrome, Immunodeficiency 121 with autoinflammation, Keratosis linearis-ichthyosis congenita-sclerosing keratoderma syndrome, Nakajo syndrome and 1 more
Proteasome
Pathway · q=4.11e-12
Cluster 464 6 Cholesteatoma, Intellectual developmental disorder, autosomal dominant 41, Intellectual disability with autism spectrum disorder, Mental retardation, autosomal dominant 41, Pierpont syndrome and 1 more
regulation of cell population proliferation
GO · q=2.72e-5
Cluster 465 6 Autosomal dominant hypophosphatasia, Autosomal recessive hypophosphatasia, Childhood hypophosphatasia, Hypophosphatasia, Micromelia and 1 more
response to lipopolysaccharide
GO · q=2.42e-3
Cluster 466 6 Autosomal recessive nonsyndromic deafness 97, Deafness, autosomal recessive 97, Dysplasia of larynx, Malignant bladder paraganglioma, Mixed cell type cancer and 1 more
Non-small cell lung cancer
Pathway · q=1.22e-6
Cluster 467 6 Cerebral sinovenous thrombosis, Congenital factor ii deficiency, Congenital prothrombin deficiency, Hemophilia b, Pregnancy loss, recurrent, 2 and 1 more
hemostasis
GO · q=2.14e-8
Cluster 468 6 Axonal neuropathy and neurodevelopmental disorder (digfan syndrome), Charcot-Marie-Tooth disease axonal type 2Z, Developmental delay with impaired growth and dysmorphic facies, Developmental delay, impaired speech, and behavioral abnormalities, Developmental delay, impaired speech, and behavioral abnormalities, with or without seizures and 1 more
central nervous system formation
GO · q=8.38e-3
Cluster 469 6 Cryptogenic multifocal ulcerous stenosing enteritis, Curling ulcer, Cytosolic phospholipase-a2 alpha deficiency associated bleeding disorder, Gastrointestinal ulceration, recurrent, with dysfunctional platelets, Neurodevelopmental disorder with seizures and 1 more
response to xenobiotic stimulus
GO · q=6.44e-5
Cluster 470 6 Congenital cerebral hernia, Dandy-walker syndrome, Joubert syndrome 21, Joubert syndrome 30, Joubert syndrome with jeune asphyxiating thoracic dystrophy and 1 more
cell migration involved in coronary angiogenesis
GO · q=1.53e-2
Cluster 471 6 Intrauterine growth restriction, Mitochondrial complex v (atp synthase) deficiency, nuclear type, Mitochondrial complex v (atp synthase) deficiency, nuclear type 1, Mitochondrial complex v (atp synthase) deficiency, nuclear type 2, Mitochondrial encephalocardiomyopathy and 1 more
mitochondrial proton-transporting ATP synthase complex assembly
GO · q=1.25e-4
Cluster 472 6 Cyanosis, Cyanosis transient neonatal, Delta-beta thalassemia, Fetal hemoglobin quantitative trait locus 1, Hemoglobin f disease and 1 more
carbon dioxide transport
GO · q=2.02e-9
Cluster 473 6 Benign fasciculation-cramp syndrome, Bronchial hyperreactivity, Charcot-Marie-Tooth disease axonal type 2F, Cramp-fasciculation syndrome, Genetic peripheral neuropathy and 1 more
antimicrobial humoral immune response mediated by antimicrobial peptide
GO · q=2.05e-7
Cluster 474 6 Beta-hexosaminidase a deficiency, Gm2 gangliosidosis, Gm2-gangliosidosis, several forms, tay-sachs disease, Hex a pseudodeficiency, Hexosaminidase activator deficiency and 1 more
ganglioside catabolic process
GO · q=5.83e-8
Cluster 475 6 Bile acid conjugation defect, Genetic lipodystrophy, Hypercholanemia, Hypercholanemia, familial 3, Hypercholanemia, familial, 1 and 1 more
Bile secretion
Pathway · q=5.90e-5
Cluster 476 6 Borderline personality disorder, Cleft lip/palate with abnormal thumbs and microcephaly, Immunodeficiency 109 with lymphoproliferation, Juberg-hayward syndrome, Kidney neoplasms and 1 more
Negative feedback regulation of MAPK pathway
Pathway · q=1.33e-7
Cluster 477 6 Bundle branch block, Expressive language delay, Intellectual developmental disorder expressive speech dysmorphic, Intellectual developmental disorder speech dysmorphic, Intellectual developmental disorder, autosomal dominant 29 and 1 more
positive regulation of myoblast differentiation
GO · q=6.22e-3
Cluster 478 6 Brain anomalies ectodermal dysplasia skeletal malformations hirschsprung disease syndrome, Bresek syndrome, Ichthyosis follicularis, atrichia, and photophobia with or without brain anomalies, retardation, ectodermal dysplasia, skeletal malformations, hirschsprung disease, ear/eye anomalies, cleft palate/cryptorchidism, and kidney dysplasia/hypoplasia, Ifap syndrome 1, with or without bresheck syndrome, Keratosis follicularis spinulosa decalvans, x-linked and 1 more
bone maturation
GO · q=6.91e-3
Cluster 479 6 Brown tendon sheath syndrome, Dystonia 4, hypomyelinating leukodystrophy 6, Dystonia 4, torsion, autosomal dominant, Hypomyelination with atrophy of the basal ganglia and cerebellum, Neurologic disorder and 1 more
rhombomere 6 development
GO · q=4.26e-3
Cluster 480 6 Caffey disease, Combined osteogenesis imperfecta and ehlers-danlos syndrome, Cortical congenital hyperostosis, Ehlers-danlos syndrome, cardiac valvular type, Maternal hypertension and 1 more
Platelet Aggregation (Plug Formation)
Pathway · q=8.03e-5
Cluster 481 6 Congenital palmoplantar and perioral keratoderma of olmsted, Erythrokeratodermia variabilis et progressiva 7, Olmsted syndrome, Palmoplantar keratoderma, nonepidermolytic, focal, Palmoplantar keratoderma, nonepidermolytic, focal 2 and 1 more
negative regulation of hair cycle
GO · q=6.11e-3
Cluster 482 6 Caffey syndrome, type 1, Early-onset progressive encephalopathy-spastic ataxia-distal spinal muscular atrophy syndrome, Encephalopathy, progressive, with amyotrophy and optic atrophy, Hypoparathyroidism-retardation-dysmorphism syndrome, Kenny-caffey syndrome and 1 more
muscle atrophy
GO · q=6.91e-3
Cluster 483 6 Candidiasis, familial, 2, Candidiasis, familial, 9, Chronic mucocutaneous candidiasis, Deep dermatophytosis, Immunodeficiency 103, susceptibility to fungal infections and 1 more
positive regulation of T-helper 17 type immune response
GO · q=1.87e-4
Cluster 484 6 Capillary infantile hemangioma, Congenital heart defects, multiple types, 7, Fetal hydrops, Lymphatic malformation 1, Lymphedema, hereditary, ia and 1 more
lymph vessel development
GO · q=3.92e-8
Cluster 485 6 Congenital heart defects, multiple types, 1, x-linked, Congenital heart disease with heterotaxy syndrome, Dextrocardia, Gut malrotation, Heterotaxy, visceral, 1, x-linked and 1 more
determination of left/right symmetry
GO · q=2.93e-4
Cluster 486 6 Cataract 46, juvenile-onset, Cataract 46, juvenile-onset, with or without arrhythmic cardiomyopathy, Congenital hypoplasia of clavicle, Early progeroid syndrome, Microstomia and 1 more
heart formation
GO · q=6.11e-3
Cluster 487 6 Dc type 4 and 5, Dyskeratosis congenita, autosomal dominant 4, Dyskeratosis congenita, autosomal recessive 5, Dyskeratosiscongenita, autosomal dominant 4, Telomere syndrome and 1 more
Telomere Extension By Telomerase
Pathway · q=8.45e-9
Cluster 488 6 Catel-manzke syndrome, Congenital nad deficiency disorder, Congenital vertebral-cardiac-renal anomalies syndrome, Hydroxykynureninuria, Nad deficiency disorder and 1 more
'de novo' NAD+ biosynthetic process from L-tryptophan
GO · q=1.83e-7
Cluster 489 6 CBL-related disorder, Cerebral arterial disease, Cerebral artery occlusion, Early onset vitamin b6 dependent epilepsy, Juvenile myelomonocytic leukemia and 1 more
vitamin B6 metabolic process
GO · q=6.91e-3
Cluster 490 6 Cda iii, Congenital dyserythropoietic anemia, Glutaric aciduria 1, Glutaricacidemia, Glutaryl-CoA dehydrogenase deficiency and 1 more
erythrocyte differentiation
GO · q=3.80e-4
Cluster 491 6 Disseminated superficial actinic porokeratosis, Porokeratosis, Porokeratosis 1, multiple types, Porokeratosis 7, multiple types, Porokeratosis 9, multiple types and 1 more
isopentenyl diphosphate biosynthetic process, mevalonate pathway
GO · q=1.69e-8
Cluster 492 6 Central areolar choroidal dystrophy, Choroidal dystrophy, Choroidal sclerosis, Choroideremia, Cone dystrophy 3 and 1 more
visual perception
GO · q=1.23e-9
Cluster 493 6 Central vertigo, Deafness, autosomal recessive 36, Deafness, autosomal recessive 84b, Maleylacetoacetate isomerase deficiency, Peripheral vertigo and 1 more
regulation of sodium ion transport
GO · q=2.77e-3
Cluster 494 6 Congenital neck anomaly, Deglutition disorder, Distal nebulin myopathy, Early-onset myopathy-areflexia-respiratory distress-dysphagia syndrome, Nemaline myopathy 2 and 1 more
tRNA-type intron splice site recognition and cleavage
GO · q=4.42e-8
Cluster 495 6 Cerebro-oculo-facio-skeletal syndrome type 1, Cerebrooculofacioskeletal syndrome, Cockayne syndrome, De sanctis-cacchione syndrome, Hepatorenal syndrome and 1 more
Nucleotide excision repair
Pathway · q=7.29e-15
Cluster 496 6 Cerebroretinal microangiopathy with calcifications and cysts, Coats plus syndrome, Congenital chromosomal disease, Melanoma, cutaneous malignant, susceptibility to, 10, Rauch-steindl syndrome and 1 more
negative regulation of telomere maintenance via telomerase
GO · q=1.66e-8
Cluster 497 6 Charcot-Marie-Tooth disease axonal type 2N, Developmental and epileptic encephalopathy, 29, Early-onset epileptic encephalopathy with persistent myelination defect, Leukoencephalopathy, Leukoencephalopathy, hereditary diffuse, with spheroids 2 and 1 more
regulation of cytoplasmic translational fidelity
GO · q=6.91e-3
Cluster 498 6 Childhood-onset sensorineural hearing impairment, Hydrops with lactic acidosis and sideroblastic anemia, Muscular dystrophy, congenital hearing loss, and ovarian insufficiency syndrome, Perrault syndrome, Perrault syndrome 2 and 1 more
mitochondrial translation
GO · q=5.21e-5
Cluster 499 6 Cholecystitis, Hereditary spastic paraplegia 11, Intellectual developmental disorder, autosomal dominant 7, Mental retardation, autosomal dominant 7, Mucosulfatidosis and 1 more
cholesterol efflux
GO · q=7.45e-3
Cluster 500 6 Chopra-amiel-gordon syndrome, Intellectual developmental disorder dysmorphic ptosis, Neurodevelopmental disorder with or without cataracts and movement disorder, Neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities, Syndromic complex neurodevelopmental disorder and 1 more
regulation of DNA-templated transcription
GO · q=3.19e-3
Cluster 501 6 Choreoathetosis, Cognitive impairment with or without cerebellar ataxia, Focal onset epileptic seizure, Myoclonus, familial, 2, Paroxysmal kinesigenic dyskinesias and 1 more
locomotory behavior
GO · q=1.01e-3
Cluster 502 6 Chronic pain, Erythermalgia, primary, Hereditary sensory and autonomic neuropathy type 2d, Indifference to pain, congenital, autosomal recessive, Primary erythromelalgia and 1 more
action potential propagation
GO · q=1.90e-3
Cluster 503 6 Macrothrombocytopenia, isolated, Quadriceps sparing myopathy, Sialuria, Stormorken syndrome, Thrombocytopenia 12 with or without myopathy and 1 more
regulation of store-operated calcium entry
GO · q=4.40e-4
Cluster 504 6 Colorectal cancer susceptibility, Mandibular hypoplasia-deafness-progeroid syndrome, Non-severe combined immunodeficiency due to polymerase delta deficiency, Paraquat lung disease, Polyposis and colorectal cancer syndrome and 1 more
PCNA-Dependent Long Patch Base Excision Repair
Pathway · q=8.05e-6
Cluster 505 6 Congenital aortic valve atresia, Congenital mitral valve atresia, Intellectual developmental disorder language autism, Intellectual developmental disorder seizures hypotonia skeletal, Intellectual developmental disorder with language impairment and with or without autistic features and 1 more
regulation of macrophage colony-stimulating factor production
GO · q=3.19e-3
Cluster 506 6 Fontaine progeroid syndrome, Hypertrichosis, progeroid appearance, and mitochondrial dysfunction (gorlin-chaudhry-moss syndrome ), Mitochondrial DNA depletion syndrome 12B (cardiomyopathic type), autosomal recessive, Progressive external ophthalmoplegia with mitochondrial dna deletions 3, Progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 2 and 1 more
mitochondrial ATP transmembrane transport
GO · q=1.86e-5
Cluster 507 6 Congenital cystic kidney disease, Joubert syndrome 20 (includes developmental delay), Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome, Meckel syndrome 12, Meckel syndrome 14 and 1 more
neuroepithelial cell differentiation
GO · q=1.64e-4
Cluster 508 6 Congenital mirror movements, Fanconi anemia, complementation group r, Gaze palsy, familial horizontal, with progressive scoliosis 1, Horizontal gaze palsy with progressive scoliosis, Mirror movements and 1 more
anterior/posterior axon guidance
GO · q=5.37e-5
Cluster 509 6 Corneal opacity, Gm1 gangliosidosis, Mucopolysaccharidosis type 4B, Mucopolysaccharidosis type ivb (morquio), Proximal renal tubular acidosis and 1 more
MPS IV - Morquio syndrome B
Pathway · q=5.47e-3
Cluster 510 6 Hemimegalencephaly, Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome, Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1, Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2, Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3 and 1 more
Cellular senescence
Pathway · q=3.30e-10
Cluster 511 6 Cutis marmorata, Evans syndrome, Immune deficiency, autoimmune disease and intellectual disability, Immunodeficiency 78 with autoimmunity and developmental delay, Tpp2 deficiency and 1 more
response to thyroxine
GO · q=6.91e-3
Cluster 512 6 Deafness-enamel hypoplasia-nail defects syndrome, Heimler syndrome 1, Peroxisomal biogenesis disorder 1a (neonatal adrenoleukodystrophy and infantile refsum disease), Peroxisomal disorder, Peroxisome biogenesis disorder due to PEX1 defect and 1 more
Peroxisomal protein import
Pathway · q=5.25e-10
Cluster 513 6 Deafness, autosomal recessive 4, with enlarged vestibular aqueduct, Deafness, autosomal recessive, 4, Goitre, Mondini defect, Sensorineural deafness and 1 more
Thyroid hormone synthesis
Pathway · q=8.01e-5
Cluster 514 6 East syndrome, Enlarged vestibular aqueduct, Littles disease, Seizures, sensorineural deafness, ataxia, impaired intellectual development, and electrolyte imbalance, Seizures, tonic-clonic, photosensitive and 1 more
synaptic vesicle maturation
GO · q=3.45e-4
Cluster 515 6 Donohue syndrome, Insulin resistant diabetes mellitus, Insulin-resistant diabetes mellitus with acanthosis nigricans, Leprechaunism, Rabson-mendenhall syndrome and 1 more
mitotic spindle organization
GO · q=4.94e-3
Cluster 516 6 Intellectual developmental disorder, autosomal dominant 74, Microphthalmia, isolated, with coloboma, Microphthalmia, isolated, with coloboma 10, Microphthalmia/coloboma 10, Progressive retinal dystrophy due to retinol transport defect and 1 more
embryonic skeletal system development
GO · q=1.68e-3
Cluster 517 6 Early-onset hypertension with severe exacerbation in pregnancy, Pseudohyperaldosteronism type 2, Pseudohypoaldosteronism, Pseudohypoaldosteronism 1, autosomal dominant, Pseudohypoaldosteronism type i, autosomal dominant and 1 more
negative regulation of sodium ion transport
GO · q=1.97e-5
Cluster 518 6 Epidermolytic hyperkeratosis 2a, Epidermolytic hyperkeratosis 2b, autosomal recessive, Ichthyosis histrix, lambert type, Ichthyosis with confetti, Pachyonychia congenita and 1 more
intermediate filament organization
GO · q=3.14e-10
Cluster 519 6 Episodic ataxia type 1, Episodic kinesigenic dyskinesia, Hereditary continuous muscle fiber activity, Myokymia, Myokymia isolated 1 and 1 more
Voltage gated Potassium channels
Pathway · q=1.39e-3
Cluster 520 6 Familial infantile convulsions with paroxysmal choreoathetosis, Infantile convulsions and choreoathetosis, Movement disorders, Neurodevelopmental and movement disorder with or without seizures, Paroxysmal dystonia and 1 more
negative regulation of short-term synaptic potentiation
GO · q=1.90e-3
Cluster 521 6 Erythrocyte udp-galactose-4-epimerase deficiency, Galactose epimerase deficiency, Galactose mutarotase deficiency, Galactosemia, Udp-glucose 4-epimerase deficiency and 1 more
galactose catabolic process via UDP-galactose, Leloir pathway
GO · q=8.11e-13
Cluster 522 6 Genetic hyperferritinemia without iron overload, Hereditary hyperferritinemia with congenital cataracts, Hyperferritinemia, Hyperferritinemia with or without cataract, L-ferritin deficiency and 1 more
Scavenging by Class H Receptors
Pathway · q=7.86e-3
Cluster 523 6 Hereditary spastic paraplegia 8, Intellectual disability, congenital cardiac malformation and dandy-walker malformation, Ritscher-schinzel syndrome 1, Ritscher-schinzel syndrome 3, Ritscher-schinzel syndrome 4 and 1 more
Golgi to plasma membrane transport
GO · q=8.37e-4
Cluster 524 5 11p11.2 deletion syndrome, Frontonasal dysplasia with alopecia and genital anomaly, Intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures, Parietal foramina, Potocki-shaffer syndrome
embryonic hindlimb morphogenesis
GO · q=6.86e-4
Cluster 525 5 Exostoses, Exostoses, multiple, type 1, Exostoses, multiple, type 2, Seizures, scoliosis, and macrocephaly/microcephaly syndrome, Trichorhinophalangeal syndrome type 2
fluid transport
GO · q=3.79e-4
Cluster 526 5 Conductive hearing loss, Deafness autosomal dominant type 13, Deafness, autosomal recessive 53, Fibrochondrogenesis 2, Weissenbacher-zweymueller syndrome
sensory perception of sound
GO · q=3.71e-4
Cluster 527 5 46,xy disorder of sex development, Disorders of sex development, Familial male precocious puberty, Luteinizing hormone resistance, Testotoxicosis
Steroid hormone biosynthesis
Pathway · q=6.62e-12
Cluster 528 5 17q24.2 microdeletion syndrome, Developmental and speech delay, postnatal microcephaly, and dysmorphic features, Intellectual disability facial dysmorphism skeletal anomalies syndrome, Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies, Stankiewicz-isidor syndrome
embryonic placenta development
GO · q=2.47e-2
Cluster 529 5 Bulimia, Dysphonia, Intermittent explosive disorder, Perrault syndrome 5, Progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant 3
cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration
GO · q=1.53e-2
Cluster 530 5 Adams-oliver syndrome, Autoinflammation, immune dysregulation, and eosinophilia, Giant lymph node hyperplasia, Limb, scalp and skull defects, Ventricular outflow obstruction
ventricular trabecula myocardium morphogenesis
GO · q=3.68e-6
Cluster 531 5 Dopa-responsive dystonia, Dystonia, dopa-responsive, with or without hyperphenylalaninemia, GTP cyclohydrolase I deficiency, Hyperphenylalaninemia, bh4-deficient, b, Sepiapterin reductase deficiency
positive regulation of nitric-oxide synthase activity
GO · q=2.75e-5
Cluster 532 5 Beta-hydroxyisobutyryl-coa deacylase deficiency, Cowchock syndrome, Severe x-linked mitochondrial encephalomyopathy, X-linked hereditary sensory and autonomic neuropathy with deafness, X-linked spondyloepimetaphyseal dysplasia
protein import into mitochondrial intermembrane space
GO · q=1.09e-2
Cluster 533 5 Dystonia, Dystonia 37, early-onset, with striatal lesions, Dystonia musculorum deformans, Focal dystonia, Genetic torsion dystonia
tetrahydrobiopterin biosynthetic process
GO · q=3.42e-6
Cluster 534 5 3-methylglutaconic aciduria, type vii, with cataracts, neurologic involvement and neutropenia, Chronic recurrent multifocal osteomyelitis with congenital dyserythropoietic anemia, Iron-refractory iron deficiency anemia, Majeed syndrome, Microcytic anemia
multicellular organismal-level iron ion homeostasis
GO · q=1.30e-3
Cluster 535 5 Congenitally uncorrected transposition of the great arteries, Double outlet right ventricle, Right atrial isomerism, Right isomerism, Transposition of the great arteries
heart development
GO · q=1.25e-5
Cluster 536 5 Cardiac-urogenital syndrome, Encephalitis/encephalopathy, mild, with reversible myelin vacuolization, Hypogonadotropic hypogonadism 8 with or without anosmia, Renal tubular acidosis, distal, 2, with progressive sensorineural hearing loss, Urogenital abnormalities
male gonad development
GO · q=8.87e-4
Cluster 537 5 Abnormal heart morphology, Abnormality of the urinary system, Deafness, autosomal dominant, 75, Developmental delay with or without dysmorphic facies and autism, Developmental delay with or without intellectual or behavioral abnormalities
regulation of DNA repair
GO · q=5.53e-3
Cluster 538 5 Abnormality of the amniotic fluid, Abnormality of the corpus callosum, Cerebral atrophy, Cns hypomyelination, Short long bone
negative regulation of growth rate
GO · q=1.30e-2
Cluster 539 5 Carotid atherosclerosis, Coffin-siris syndrome, Rhabdoid tumor predisposition syndrome, Small cell ovary carcinoma, Syndromic intellectual disability and developmental delay
regulation of G0 to G1 transition
GO · q=4.58e-21
Cluster 540 5 Absence of fingerprints-congenital milia syndrome, Adermatoglyphia, Basan syndrome, Huriez syndrome, Palmoplantar keratoderma
morphogenesis of an epithelium
GO · q=2.39e-3
Cluster 541 5 Acatalasemia, Aortic disease, Bonnevie-ullrich syndrome, Turner syndrome, Ureteral calculi
Detoxification of Reactive Oxygen Species
Pathway · q=6.07e-7
Cluster 542 5 Alacrima, achalasia, and intellectual disability syndrome, Glucocorticoid deficiency with achalasia, Intellectual developmental disorder movement cerebellar, Intellectual disability with strabismus syndrome, Triple a syndrome
negative regulation of phosphate metabolic process
GO · q=6.11e-3
Cluster 543 5 Central hypothyroidism, Congenital nystagmus, Imperforate anus, Neurooculorenal syndrome, Nystagmus 8, congenital, autosomal recessive
visual perception
GO · q=8.90e-5
Cluster 544 5 Dowling degos disease, Dowling-degos disease 1, Epidermolysis bullosa simplex 2d, generalized, intermediate or severe, autosomal recessive, Epidermolysis bullosa simplex 2e, with migratory circinate erythema, Epidermolysis bullosa simplex 2f, with mottled pigmentation
regulation of Notch signaling pathway
GO · q=2.69e-6
Cluster 545 5 Acromegaly, Chromosome xq26.3 duplication syndrome, Growth hormone-secreting pituitary adenoma, Pituitary adenoma 1, multiple types, X-linked acrogigantism due to xq26 microduplication
cellular response to glucagon stimulus
GO · q=1.18e-3
Cluster 546 5 Erythrocytosis, familial, 1, Familial polycythemia, Growth retardation, mild developmental delay, chronic hepatitis syndrome, Myelofibrosis, somatic, Polycythemia, primary familial and congenital
cellular response to interleukin-3
GO · q=6.49e-5
Cluster 547 5 Blindness, Epileptic encephalopathy, early infantile, 38, Microphthalmia with cataracts and iris abnormalities, Microphthalmia, isolated 2, Microphthalmia/coloboma 3
visual perception
GO · q=2.44e-8
Cluster 548 5 Alazami-yuan syndrome, Cornelia de lange syndrome, De lange syndrome, Nut midline carcinoma, Wiedemann-steiner syndrome
establishment of mitotic sister chromatid cohesion
GO · q=2.75e-9
Cluster 549 5 Alkylglycerone-phosphate synthase deficiency, Chondrodysplasia, Chondrodysplasia with joint dislocations, gpapp type, Glyceronephosphate O-acyltransferase deficiency, Rhizomelic chondrodysplasia punctata
ether lipid biosynthetic process
GO · q=6.05e-6
Cluster 550 5 Carasil syndrome, Cerebral microangiopathy, Cognitive impairment, Degenerative disc disease, Psychiatric disturbance
renal tubule morphogenesis
GO · q=1.30e-2
Cluster 551 5 Alpha-1 antichymotrypsin deficiency, Hemolytic disease of fetus and newborn, Rh deficiency syndrome, Rh isoimmunization, Rh-null, amorph type
ammonium homeostasis
GO · q=5.28e-8
Cluster 552 5 Alport syndrome 2, autosomal recessive, Benign familial pemphigus, Diffuse mesangial sclerosis, Hailey-hailey disease, Hematuria, benign familial, 1
Laminin interactions
Pathway · q=3.94e-4
Cluster 553 5 Atrial septal defect, Bafopathy, Congenital heart septal defect, Renpenning syndrome, Ventricular septal defect
heart development
GO · q=2.93e-13
Cluster 554 5 Amish nemaline myopathy, Childhood-onset nemaline myopathy, Nemaline myopathy 5, Nemaline myopathy 5a, autosomal recessive, severe infantile, Nemaline myopathy 5c, autosomal dominant
transition between fast and slow fiber
GO · q=5.72e-5
Cluster 555 5 Autosomal recessive osteopetrosis 2, Bone resorption, Osteolysis, Otosclerosis, Uremia
skeletal system development
GO · q=5.89e-11
Cluster 556 5 Amyotrophic lateral sclerosis, susceptibility to, 25, Genetic neurodegenerative disease, Inherited neurodegenerative disorder, Severe neonatal myoclonus, Spastic paraplegia 10, autosomal dominant
pantothenate transmembrane transport
GO · q=4.26e-3
Cluster 557 5 Analbuminemia, Anuria, Blood protein disorder, Congenital analbuminemia, Dysalbuminemic hyperthyroxinemia
positive regulation of epidermal growth factor receptor signaling pathway
GO · q=4.71e-4
Cluster 558 5 Brachydactyly-short stature-retinits pigmentosa syndrome, Diverticulitis, Metaphyseal chondrodysplasia with retinitis pigmentosa, Osteonecrosis, Retinitis pigmentosa with or without skeletal anomalies
synaptic membrane adhesion
GO · q=2.14e-4
Cluster 559 5 Coach syndrome, Congenital hypoplasia of femur, Intellectual development disorder, truncal obesity, retinal dystrophy, and micropenis, Joubert syndrome 1, Mental retardation, truncal obesity, retinal dystrophy, and micropenis
cilium assembly
GO · q=4.01e-7
Cluster 560 5 Aneuploidy, Autosomal-dominant microcephaly associated with lymphedema and/or chorioretinopathy, Chromosomal instability, Microcephaly with or without chorioretinopathy, lymphedema, or intellectual disability, Oocyte/zygote/embryo maturation arrest 9
spindle organization
GO · q=1.32e-5
Cluster 561 5 Floor of mouth mucoepidermoid carcinoma, Gestational trophoblastic disease, Hidradenoma, Mucoepidermoid carcinoma of submandibular gland, Warthin tumor
positive regulation of transcription by RNA polymerase II
GO · q=1.83e-3
Cluster 562 5 C2 deficiency, Immunodeficiency due to c1, c4, or c2 component complement deficiency, Immunodeficiency, common variable, 7, Irritant dermatitis, Lupus
Interferon gamma signaling
Pathway · q=3.27e-5
Cluster 563 5 Antithrombin deficiency, Bronchiolitis, Diffuse panbronchiolitis, Interstitial lung disease 2, Interstitial systitis
IL-17 signaling pathway
Pathway · q=8.04e-4
Cluster 564 5 Combined molybdoflavoprotein enzyme deficiency, Glycoprotein ia deficiency, Molybdenum cofactor deficiency b, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B1
molybdopterin cofactor biosynthetic process
GO · q=2.29e-5
Cluster 565 5 Aortic stenosis, Aortic valve disease, Brain aneurysm, Carey-fineman-ziter syndrome, Trimethylaminuria
aortic valve morphogenesis
GO · q=3.53e-7
Cluster 566 5 Craniofacial dysostosis, Lacrimo-auriculo-dento-digital syndrome (ladd), Lacrimoauriculodentodigital syndrome, Ladd syndrome, Saethre-chotzen syndrome
fibroblast growth factor receptor signaling pathway involved in mammary gland specification
GO · q=7.87e-6
Cluster 567 5 Barrett esophagus, Camptodactyly, Esophageal disease, Esophageal ulcer, Hypomagnesemia 5, renal, with ocular involvement
positive regulation of gene expression
GO · q=9.32e-7
Cluster 568 5 Apnea, Butyrylcholinesterase deficiency, Paresis, Periodic fever, menstrual cycle-dependent, Trismus
Defective SLC6A5 causes hyperekplexia 3 (HKPX3)
Pathway · q=4.58e-3
Cluster 569 5 Apocrine adenocarcinoma, Cervical adenosarcoma, Hyperparathyroidism 2 with jaw tumors, Hyperparathyroidism, familial primary, Parathyroid neoplasm
Prostate cancer
Pathway · q=3.75e-11
Cluster 570 5 Congenital hypothyroidism, Congenital hypothyroidism without goiter, Congenital thyroid atrophy, Testicular disease, Thyroid agenesis
thyroid gland development
GO · q=1.65e-11
Cluster 571 5 Apraxia, Cataplexy, Developmental delay with variable intellectual disability, Niemann-pick disease type c1, Ophthalmoplegia
negative regulation of neuron remodeling
GO · q=1.09e-2
Cluster 572 5 Arima syndrome, Joubert syndrome 14, Joubert syndrome with oculorenal defect, Meckel syndrome 2, Meckel syndrome type 4
cell projection organization
GO · q=5.50e-9
Cluster 573 5 Charcot-Marie-Tooth disease type 2A1, Charcot-Marie-Tooth disease type 4C, Congenital hemihypertrophy, Congenital joint contractures, Mononeuropathy of the median nerve, mild
PI3K/AKT activation
Pathway · q=6.19e-4
Cluster 574 5 Ataxia with oculomotor apraxia, Ataxia with oculomotor apraxia and hypoalbuminemia, Dna repair-deficiency disorders, Epileptic encephalopathy, early infantile, 10, Microcephaly, seizures, and developmental delay
DNA repair
GO · q=2.40e-4
Cluster 575 5 Mirage syndrome, Monosomy 7 myelodysplasia and leukemia syndrome 2, Myelodysplasia, infection, restriction of growth, adrenal hypoplasia, genital phenotypes, enteropathy (mirage), Normophosphatemic familial tumoral calcinosis, Spectrum and myeloid neoplasm risk
endosomal vesicle fusion
GO · q=1.86e-2
Cluster 576 5 Autoinflammatory syndrome, Hemophagocytic lymphohistiocytosis, Hemophagocytic lymphohistiocytosis, familial, 2, Hereditary hemophagocytic lymphohistiocytosis, Immune dysregulation and systemic hyperinflammation syndrome
pattern recognition receptor signaling pathway
GO · q=2.56e-7
Cluster 577 5 Erythematosquamous dermatosis, Neurodevelopmental disorder with poor growth, large ears, and dysmorphic facies, Pityriasis rubra pilaris, Sebaceous gland disease, Seborrheic dermatitis
melanin biosynthetic process
GO · q=3.09e-4
Cluster 578 5 Bietti crystalline corneoretinal dystrophy, Coagulation disorder, Congenital prekallikrein deficiency, Fletcher factor (prekallikrein) deficiency, Inherited prekallikrein deficiency
The canonical retinoid cycle in rods (twilight vision)
Pathway · q=2.22e-4
Cluster 579 5 Café-au-lait macules, Congenital malformation syndromes associated with short stature, Increased nuchal translucency, Schwannomatosis, Schwannomatosis-2, susceptibility to
Renal cell carcinoma
Pathway · q=2.79e-4
Cluster 580 5 Auditory neuropathy with optic atrophy, Autosomal recessive optic atrophy, OPA7 type, Multiple mitochondrial dysfunctions syndrome 9b, Optic atrophy mitochondrial dysfunction syndrome, Optic atrophy-ataxia-peripheral neuropathy-global developmental delay syndrome
Electron transport from NADPH to Ferredoxin
Pathway · q=8.62e-3
Cluster 581 5 Autism, intellectual disability, basal ganglia dysfunction and epilepsy, Intellectual developmental disorder seizures extrapyramidal, Mental retardation, autosomal dominant 24, Neurodevelopmental disorder with hypotonia, impaired expressive language, and with or without seizures, Vulto-van silfhout-de vries syndrome
regulation of grooming behavior
GO · q=9.07e-3
Cluster 582 5 Parotid gland pleomorphic adenoma, Salivary gland basal cell adenocarcinoma, Salivary gland carcinoma ex pleomorphic adenoma, Salivary gland mucoepidermoid carcinoma, Salivary gland pleomorphic adenoma
Prostate cancer
Pathway · q=4.91e-10
Cluster 583 5 Autoimmune enteropathy and endocrinopathy, Candidiasis, familial, 7, Immunodeficiency 31b, Immunodeficiency 31c, autosomal dominant, Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency
negative regulation of metanephric nephron tubule epithelial cell differentiation
GO · q=1.90e-3
Cluster 584 5 Microphthalmia syndromic type 3, optic nerve hypoplasia and abnormalities of the central nervous system, Microphthalmia, syndromic 3, Optic nerve hypoplasia and abnormalities of the central nervous system, Sensorineural hearing loss, Thoracic neoplasms
pituitary gland development
GO · q=3.28e-3
Cluster 585 5 Autoinflammation with arthritis and dyskeratosis, Corneal intraepithelial dyskeratosis-palmoplantar hyperkeratosis-laryngeal dyskeratosis syndrome, Palmoplantar carcinoma, multiple self-healing, Respiratory papillomatosis, juvenile recurrent, congenital, Vitiligo-associated multiple autoimmune disease susceptibility 1
canonical inflammasome complex assembly
GO · q=3.19e-3
Cluster 586 5 Autoinflammation with arthritis and vasculitis, Corticobasal syndrome, Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 8, Frontotemporal dementia and/or amyotrophic lateral sclerosis 4, Reticulate acropigmentation of kitamura
constitutive protein ectodomain proteolysis
GO · q=4.26e-3
Cluster 587 5 Autonomic nervous system disease, Bladder dysfunction, Bladder dysfunction, autonomic, with impaired pupillary reflex and secondary cakut, Hirschsprung disease, cardiac defects, and autonomic dysfunction, Urinary bladder dysfunction
regulation of acetylcholine secretion, neurotransmission
GO · q=4.26e-3
Cluster 588 5 Bilateral generalized polymicrogyria, Microcephalic primordial dwarfism, Microcephaly with or without short stature, Microcephaly, epilepsy, cerebral and/or cerebellar atrophy and short stature, Microcephaly, short stature, and polymicrogyria with seizures
centriole replication
GO · q=5.09e-4
Cluster 589 5 Cardiomyopathy, Cardiomyopathy, dilated, 2h, Dilated cardiomyopathy, Dilated cardiomyopathy 1M, Hypertrophic cardiomyopathy
cardiac muscle contraction
GO · q=2.30e-30
Cluster 590 5 Bartsocas-papas syndrome, Condition, Curly hair ankyloblepharon nail dysplasia syndrome, Popliteal pterygium syndrome, Popliteal pterygium syndrome, bartsocas-papas type 1
skin development
GO · q=1.08e-3
Cluster 591 5 Basal ganglia disease, Fahr's disease, Idiopathic basal ganglia calcification, Myopathy with extrapyramidal signs, Primary familial brain calcification
negative regulation of synaptic transmission, glutamatergic
GO · q=1.95e-5
Cluster 592 5 Beare-stevenson cutis gyrata syndrome, Crouzon syndrome, Jackson-weiss syndrome, Pfeiffer syndrome, Triple negative breast cancer
fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development
GO · q=2.39e-4
Cluster 593 5 Benign concentric annular macular dystrophy, Congenital blindness, Dominant retinopathy, Recessive retinopathy, Retinitis pigmentosa with choroidal involvement
visual perception
GO · q=5.09e-8
Cluster 594 5 Benign ovarian mucinous tumor, Oropharyngeal dysphagia, Spinocerebellar ataxia, x-linked, X-linked non progressive cerebellar ataxia, X-linked progressive cerebellar ataxia
Ras protein signal transduction
GO · q=1.20e-5
Cluster 595 5 Inflammatory skin disease, Intellectual developmental disorder neuropsychiatric, Psoriasis vulgaris, Psoriatic arthritis, Pure spastic paraplegia
Type I diabetes mellitus
Pathway · q=8.44e-11
Cluster 596 5 Cap myopathy, Congenital generalized hypercontractile muscle stiffness syndrome, Congenital myopathy 4a, autosomal dominant, Congenital myopathy 4b, autosomal recessive, Nemaline myopathy 1, autosomal dominant or recessive
Cytoskeleton in muscle cells
Pathway · q=2.04e-4
Cluster 597 5 Bleeding esophageal varices, Esophageal and gastric varices, Esophageal varices, Sweat gland disease, Vipoma
lipid homeostasis
GO · q=4.58e-3
Cluster 598 5 Blomstrand lethal chondrodysplasia, Eiken skeletal dysplasia, Eiken syndrome, Primary failure of tooth eruption, Rickets
Parathyroid hormone synthesis, secretion and action
Pathway · q=6.16e-6
Cluster 599 5 Bone remodeling disease, Neurocardiofaciodigital syndrome, Osteochondrodysplasia, brachydactyly, and overlapping malformed digits, Synpolydactyly, Synpolydactyly, 3/3-prime/4, associated with metacarpal and metatarsal synostoses
respiratory gaseous exchange by respiratory system
GO · q=6.24e-3
Cluster 600 5 Brooke-spiegler syndrome, Familial cylindromatosis, Frontotemporal dementia and/or amyotrophic lateral sclerosis 8, Multiple familial trichoepithelioma, Trichoblastoma
Thyroid cancer
Pathway · q=6.24e-4
Cluster 601 5 Duane retraction syndrome 2, Robinow syndrome, Robinow syndrome, autosomal dominant 2, Robinow syndrome, autosomal dominant 3, Robinow syndrome, autosomal recessive 2
Wnt signaling pathway
GO · q=6.86e-10
Cluster 602 5 Dyslexia, Holocarboxylase synthetase deficiency, Male infertility acephalic spermatozoa, Parkinson disease 25, autosomal recessive early-onset, with impaired intellectual development, Specific language disorder
vocal learning
GO · q=1.54e-7
Cluster 603 5 Brain stem astrocytic neoplasm, Fibrodysplasia ossificans progressiva, Optic tract astrocytoma, Retina neoplasm, Retinitis pigmentosa 86
gastrulation
GO · q=1.04e-3
Cluster 604 5 Carbohydrate deficient glycoprotein syndrome, Coronary aneurysm, Dock2 deficiency, Mental retardation, autosomal recessive 15, Rafiq syndrome
prepulse inhibition
GO · q=6.16e-3
Cluster 605 5 Byzanthine arch palate, Child syndrome xld, Ck syndrome, Congenital hemidysplasia with ichthyosiform erythroderma and limb defects, Perisylvian polymicrogyria
prostate epithelial cord elongation
GO · q=1.22e-4
Cluster 606 5 Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy, Cerebral arteriopathy, autosomal recessive, with subcortical infarcts and leukoencephalopathy 1, Inherited thrombocytopenia, Lateral meningocele syndrome, Myofibromatosis, infantile 2
glomerular capillary formation
GO · q=9.07e-3
Cluster 607 5 Cardiac and skeletal myopathy, Cardiomyopathy, dilated, 1aa, with or without left ventricular non-compaction, Cardiomyopathy, familial hypertrophic, 23, with or without left ventricular non-compaction, Myopathy, congenital with structured cores and z-line abnormalities, Myopathy, distal, 6, adult onset
actin filament uncapping
GO · q=1.90e-3
Cluster 608 5 Carnitine palmitoyltransferase 2 deficiency, infantile, Carnitine palmitoyltransferase 2 deficiency, lethal neonatal, Carnitine palmitoyltransferase 2 deficiency, myopathic, stress-induced, Carnitine palmitoyltransferase deficiency, Carnitine palmitoyltransferase i deficiency, hepatic, type ia
carnitine shuttle
GO · q=1.28e-5
Cluster 609 5 Cataract 16, multiple types, Cataract 33, multiple types, Cataract, multiple types, Crystallinopathy with cataract, skeletal myopathy and/or cardiomyopathy, Myopathy, myofibrillar, fatal infantile hypertonic, alpha-b crystallin-related
negative regulation of intracellular transport
GO · q=7.22e-6
Cluster 610 5 Cataract 38, autosomal recessive, Congenital cataract hypertrophic cardiomyopathy mitochondrial myopathy syndrome, Sengers syndrome, Trichohepatoenteric syndrome, Triokinase and fmn cyclase deficiency
apoptotic mitochondrial changes
GO · q=9.98e-4
Cluster 611 5 Cataract-neurodevelopmental syndrome, Fatty acyl-CoA reductase 1 deficiency, Fatty acyl-CoA reductase 1 upregulation, Peroxisomal fatty acyl-coa reductase 1 disorder, Severe intellectual disability, epilepsy, and cataracts
fatty acid derivative metabolic process
GO · q=1.90e-3
Cluster 612 5 Cerebellar cortical atrophy, Elejalde syndrome, Griscelli syndrome, Griscelli syndrome type 1, Griscelli syndrome type 2
melanosome transport
GO · q=3.14e-7
Cluster 613 5 Gastroschisis, Huntington disease, Lenz-majewski hyperostotic dwarfism, Salt-sensitive hypertension, Ventriculomegaly
cellular response to hydrogen peroxide
GO · q=6.52e-7
Cluster 614 5 Cerebrofaciothoracic dysplasia, Craniofacial dysmorphism skeletal anomalies intellectual disability syndrome, Hypogonadotropic hypogonadism 16 with or without anosmia, Parenchymal hematoma, Skeletal anomalies
multi-pass transmembrane protein insertion into ER membrane
GO · q=5.02e-4
Cluster 615 5 Childhood-onset benign chorea with striatal involvement, Childhood-onset chorea with bilateral striatal lesions, Dyskinesia, limb and orofacial, infantile-onset, Striatal degeneration, autosomal dominant, Striatal degeneration, autosomal dominant 2
regulation of cAMP/PKA signal transduction
GO · q=9.70e-3
Cluster 616 5 Chime syndrome, Coloboma, congenital heart disease, ichthyosiform dermatosis, impaired intellectual development, and ear anomalies syndrome, Coloboma, congenital heart disease, ichthyosiform dermatosis, impaired intellectual development, and ear anomalies syndrome (chime), Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or impaired intellectual development, Zunich neuroectodermal syndrome
enterocyte differentiation
GO · q=3.19e-3
Cluster 617 5 Developmental and epileptic encephalopathy, 80, Disorders of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation, Hyperphosphatasia with intellectual disability syndrome, Hyperphosphatasia with intellectual disability syndrome 1, Hyperphosphatasia with intellectual disability syndrome 4
GPI anchor biosynthetic process
GO · q=4.55e-21
Cluster 618 5 Choroidal melanoma, Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 1, Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome, Spondylometaepiphyseal dysplasia, short limb-hand type, Warburg-cinotti syndrome
positive regulation of hepatic stellate cell proliferation
GO · q=1.09e-2
Cluster 619 5 Houge janssens syndrome, Intellectual developmental disorder growth behavioral, Intellectual developmental disorder macrocephaly hypotonia behavioral, Mental retardation, autosomal dominant 35, Neurodevelopmental disorder with macrocephaly and hypotonia, with or without seizures
APC truncation mutants have impaired AXIN binding
Pathway · q=2.02e-10
Cluster 620 5 Circumferential skin creases kunze type, Developmental disorder with cleft palate, cranial malformations and circumferential skin creases (kunze type), Skin creases, congenital symmetric circumferential, 1, Skin creases, congenital symmetric circumferential, 2, Symmetric circumferential skin creases, congenital, 2
spindle assembly
GO · q=2.83e-4
Cluster 621 5 Commissural facial cleft, Facial clefting, oblique, 1, Opitz gbbb syndrome, Opitz gbbb syndrome, type ii, Tessier facial cleft
cell fate determination
GO · q=6.54e-4
Cluster 622 5 Cochlear diseases, Deafness, autosomal recessive 23, Navajo neurohepatopathy, Pain insensitivity, Usher syndrome, type1d/f digenic
inner ear development
GO · q=2.60e-3
Cluster 623 5 Colobomatous optic disc macular atrophy chorioretinopathy syndrome, Mac spectrum, Microphthalmia with cataract 2, Microphthalmia, isolated, with cataract, Optic disc anomalies with retinal and/or macular dystrophy
eye development
GO · q=3.38e-2
Cluster 624 5 Colonic disease, Growth hormone insensitivity syndrome, Growth hormone insensitivity syndrome with immune dysregulation, Growth hormone insensitivity, partial, Increased responsiveness to growth hormone
positive regulation of multicellular organism growth
GO · q=3.48e-6
Cluster 625 5 Facial dysmorphism, immunodeficiency, livedo, and short stature, Fils syndrome, Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency, Xeroderma pigmentosum group F, Xfe progeroid syndrome
Dual Incision in GG-NER
Pathway · q=3.01e-4
Cluster 626 5 Colorectal cancer, hereditary nonpolyposis, type 8, Congenital chronic diarrhea with protein-losing enteropathy, Congenital diarrhea, Congenital epithelial dysplasia of intestine, Congenital tufting enteropathy
Intestinal infectious diseases
Pathway · q=1.07e-2
Cluster 627 5 Combined factor v and factor viii deficiency, Combined immunodeficiency, enteropathy spectrum, Gastrointestinal defects and immunodeficiency syndrome, Intestinal atresia, inflammatory bowel disease and immunodeficiency, Multiple intestinal atresia
Transport to the Golgi and subsequent modification
Pathway · q=4.55e-6
Cluster 628 5 Hyper-immunoglobulin e recurrent infection syndrome 5, autosomal recessive, Immunodeficiency 53, Immunodeficiency, common variable, 5, Interleukin 6 quantitative trait, Recurrent infections
response to cytokine
GO · q=7.66e-5
Cluster 629 5 Combined oxidative phosphorylation defect, Deafness, autosomal recessive 70, Deafness, autosomal recessive, 70, with or without adult-onset neurodegeneration, Mitochondrial disease with regression and lactic acidosis, Respiratory chain disorder
Aminoacyl-tRNA biosynthesis
Pathway · q=3.20e-7
Cluster 630 5 Deafness, autosomal recessive 94, Dend syndrome, Diabetes, permanent neonatal, with or without neurologic features, Diazoxide-resistant focal hyperinsulinism due to kir6.2 deficiency, Hyperinsulinemic hypoglycemia, familial, 2
Defective ABCC8 can cause hypoglycemias and hyperglycemias
Pathway · q=2.48e-6
Cluster 631 5 Congenital epileptic encephalopathy and severe neuromuscular disorder, Congenital nervous system disorder, Neurodevelopmental disorder with ataxia and tremor or dyskinetic movements, Neurodevelopmental disorder with hypotonia, epilepsy, and absent speech, Neurodevelopmental disorder with speech delay, movement abnormalities, and seizures
neuronal dense core vesicle exocytosis
GO · q=5.22e-3
Cluster 632 5 Congenital heart defect, intellectual disability, facial dysmorphism syndrome, Intellectual developmental disorder dysmorphic facial, Intellectual developmental disorder, autosomal dominant 23, Intellectual disability-facial dysmorphism syndrome due to setd5 haploinsufficiency, Mental retardation, autosomal dominant 23
positive regulation of transcription elongation by RNA polymerase II
GO · q=1.93e-3
Cluster 633 5 Congenital hypoplasia of pancreas, Maturity-onset diabetes of the young, type iv, Pancreatic agenesis 1, Pancreatic beta-cell agenesis with neonatal diabetes mellitus, Partial pancreatic agenesis
pancreas development
GO · q=2.19e-9
Cluster 634 5 Congenital keratoglobus, Glaucoma 3, primary congenital, d, Megalocornea 1, x-linked, Microspherophakia, Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma
establishment of protein localization to extracellular region
GO · q=6.91e-3
Cluster 635 5 Congenital methemoglobinemia, Cytochrome-b5 reductase deficiency, Dihydrolipoamide dehydrogenase deficiency, Methemoglobinemia due to deficiency of methemoglobin reductase, Methemoglobinemia type i and ii
2-oxoglutarate decarboxylation to succinyl-CoA
GO · q=3.19e-3
Cluster 636 5 Congenital myasthenic syndrome 2A, Congenital myasthenic syndrome 2C, Congenital myasthenic syndrome, biallelic, Congenital myasthenic syndrome, monoallelic, Myasthenic syndrome, congenital, 2c, associated with acetylcholine receptor deficiency
postsynaptic membrane organization
GO · q=3.19e-3
Cluster 637 5 Hypocalcemic vitamin d-dependent rickets, Pancreatic trypsinogen deficiency, Peptic esophagitis, Rickets due to defect in vitamin d 25-hydroxylation, Vitamin d dependent rickets
calcitriol biosynthetic process from calciol
GO · q=8.58e-8
Cluster 638 5 Hemifacial microsomia, T-cell immunodeficiency, T-cell immunodeficiency, congenital alopecia, and nail dystrophy, T-cell lymphopenia, infantile, with or without nail dystrophy, autosomal dominant, Thymic hypoplasia
hair follicle development
GO · q=2.18e-3
Cluster 639 5 Cryohydrocytosis, Distal renal tubular acidosis, Ovalocytosis, sa type cryohydrocytosis, Ovalocytosis, southeast asian, Spherocytoisis type 4
Collecting duct acid secretion
Pathway · q=5.62e-7
Cluster 640 5 Cutis laxa, autosomal dominant, 2, Cutis laxa, autosomal recessive, 1a, Cutis laxa, autosomal recessive, type ia, Demyelinating hereditary motor and sensory neuropathy, Proximal spinal muscular atrophy
DNA-templated transcription termination
GO · q=1.64e-6
Cluster 641 5 Dedifferentiated solitary fibrous tumor, Hemangiopericytoma, Hyper-immunoglobulin e syndrome 6, autosomal dominant, with recurrent infections, Meninges hemangiopericytoma, Peritoneal solitary fibrous tumor
isotype switching to IgE isotypes
GO · q=3.65e-5
Cluster 642 5 Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome, Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities, Leigh syndrome with secondary deficiency for pyruvate and alpha-ketoglutarate dehydrogenase, Lipoyltransferase deficiency, Progressive childhood encephalopathy and golgi dysfunction
protein lipoylation
GO · q=3.50e-5
Cluster 643 5 Episodic ataxia, Infancy-onset recurrent metabolic crises with encephalocardiomyopathy, Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration, Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome, Spinocerebellar ataxia 27b, late-onset
Phase 0 - rapid depolarisation
Pathway · q=1.22e-4
Cluster 644 5 Erythrocyte lactate transporter defect, Fatty acid and ketone body metabolism disorder, Fatty acid oxidation and ketone body metabolism disorder, Monocarboxylate transporter 1 deficiency, Symptomatic deficiency in lactate transport
mevalonate transport
GO · q=1.90e-3
Cluster 645 5 Hypomagnesemia 6, renal, Hypomagnesemia, seizures, and intellectual disability 1, Magnesium metabolism disorder, Renal hypomagnesemia 4, Tetany
magnesium ion transmembrane transport
GO · q=1.18e-6
Cluster 646 5 Hyper-immunoglobulin e syndrome 2, autosomal recessive, with recurrent infections, Hyper-immunoglobulin e syndrome with recurrent infections, Insulin dependent diabetes mellitus secretory diarrhea syndrome, Intellectual developmental disorder, autosomal dominant 2, Ritscher-schinzel syndrome 2
memory T cell proliferation
GO · q=4.26e-3
Cluster 647 5 Pulmonary hypertension, familial primary, 1, with or without hht, Pulmonary hypertension, primary, fenfluramine or dexfenfluramine-associated, Pulmonary venoocclusive disease 1, Right bundle branch block, Right cardiac ventricular dilatation
semi-lunar valve development
GO · q=1.90e-3
Cluster 648 5 Leukodystrophy, hypomyelinating with or without oligodontia and/or hypogonadotropic hypogonadism, Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism, Neurodevelopmental disorder with or without seizures, ataxia, spasticity, and demyelinating neuropathy, POLR3B-related disorder, Tremor-ataxia-central hypomyelination syndrome
Cytosolic sensors of pathogen-associated DNA
Pathway · q=1.05e-4
Cluster 649 5 Ichthyosis, follicular, with atrichia and photophobia syndrome, Ichthyosis, follicular, with atrichia and photophobia syndrome 2, Ifap syndrome 2, Mucoepithelial dysplasia, Urban-schosser-spohr syndrome
regulation of heart rate by chemical signal
GO · q=3.19e-3
Cluster 650 5 Immunodeficiency 73a with defective neutrophil chemotaxis and leukocytosis, Immunodeficiency 73b with defective neutrophil chemotaxis and lymphopenia, Immunodeficiency 73c with defective neutrophil chemotaxis and hypogammaglobulinemia, Neutrophil immunodeficiency syndrome, Reticular dysgenesis
regulation of mast cell chemotaxis
GO · q=3.19e-3
Cluster 651 5 Intellectual developmental disorder, autosomal dominant 62, Leber-like hereditary optic neuropathy, autosomal recessive 1, Marfanoid habitus, Very long-chain acyl-coa dehydrogenase deficiency, Williams syndrome
positive regulation of neuron projection arborization
GO · q=1.96e-3
Cluster 652 5 Mandibuloacral dysostosis, Mandibuloacral dysplasia, Obsolete lethal restrictive dermopathy, Restrictive dermopathy, Tight skin contracture syndrome
nuclear envelope organization
GO · q=5.09e-4
Cluster 653 5 Multiple mitochondrial dysfunctions syndrome, Multiple mitochondrial dysfunctions syndrome 1, Multiple mitochondrial dysfunctions syndrome 2, Post-operative acute kidney injury, Spastic paraplegia 93, autosomal recessive
iron-sulfur cluster assembly
GO · q=3.70e-3
Cluster 654 5 Nabais sa-de vries syndrome 1, Nabais sa-de vries syndrome 2, Neurodevelopmental disorder with microcephaly and dysmorphic facies, Neurodevelopmental disorder with relative macrocephaly and with or without cardiac or endocrine anomalies, Neurodevelopmental disorder, gain of function
regulation of proteolysis
GO · q=1.25e-2
Cluster 655 5 Neurodevelopmental disorder with distinct white matter changes, Neurodevelopmental disorder with hypotonia, brain anomalies, distinctive facies, and absent language, Neurodevelopmental disorder with microcephaly and seizures, Neurodevelopmental disorder with poor growth and skeletal anomalies, Renu syndrome
mRNA 3'-end processing by stem-loop binding and cleavage
GO · q=1.40e-2
Cluster 656 5 Thrombocytopenia 2, Thrombocytopenia 4, Thrombocytopenia 7, Thrombocytopenia with normal platelets, Thrombocytopenia, reduced platelet alpha granules
female meiosis II
GO · q=9.70e-3

656 clusters, largest first by default. Click a column header to re-sort, or use the search box above to jump straight to a specific disease's cluster.